ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[SMARCAL1, CCNH, SMC3, CHEK2, CHEK1, TRIM25, WDHD1, ESCO2, NEIL3, DNA2, PRKDC, CDCA5, BRIP1, RAD21, BARD1, CDC7, POLA1, ATR, FEN1, BTG2, BRCA1, BRCA2, CHAF1B, CHAF1A, ACTL6A, PARP9, SIRT1, RAD51C, PCNA, UNG, RAD54B, USP1, RAD54L, APBB1, PMS1, GINS2, GINS4, RPA1, RPA2, GTF2H1, MLH1, RPA3, TRIP13, DCLRE1A, PTTG1, RUVBL2, RUVBL1, MEN1, LIG1, MSH6, MSH2, FANCD2, TIMELESS, BLM, RNASEH2A, PSMD14, RAD51AP1, CLSPN, FANCI, FANCL, HMGA1, ISG15, FANCG, COPS5, UBE2T, JMY, CDK2, CDK1, MCM8, FOXM1, EXO1, TOPBP1, RFC5, RFC3, RFC4, RFC1, RFC2, H2AFX, SMC1A, DTL, UHRF1, POLD3, CDC45, POLD1, RBBP8, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, POLQ, MND1, RAD50, RAD51, POLE2]
GO:0007131;reciprocal meiotic recombination;9.0;1.0;0.896240625180289;9.628524252492122;175.07189671554147;6.343086423195323;0.005859498828591432;0.7206263598461826;[MND1, RAD54B, RAD50, RAD51, RAD51C, RAD21, TRIP13]
GO:0034198;cellular response to amino acid starvation;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;115.90251486529202;5.970411137910149;0.003879152867050031;0.6562464685024372;[CDKN1A, SEH1L, SESN3, EIF2AK2, EIF2S1, RRAGD, ATF3]
GO:1990090;cellular response to nerve growth factor stimulus;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;97.48528473772916;5.9928839937622085;0.003262744749111514;0.6295966787287501;[CALCA, E2F1, AKT1, ID1]
GO:0006283;transcription-coupled nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;5.486614186532078;0.006172937954381027;0.676826329833192;[CCNH, RFC5, RFC3, RFC4, RFC1, LIG1, RFC2, PCNA, POLD3, POLD1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, RPA1, RPA2, GTF2H1, COPS5, RPA3]
GO:0110032;positive regulation of G2/MI transition of meiotic cell cycle;9.0;1.0;0.896240625180289;9.628524252492122;414.4836470731219;8.67846133901236;0.013872394656472954;0.8400575416471059;[CDC25C, CDC25A]
GO:0071493;cellular response to UV-B;8.0;1.0;0.875;9.628524252492122;82.44278777713699;7.697632086000634;0.0027592859132088378;0.7686572628545723;[MFAP4, CDKN1A, MME]
GO:0071373;cellular response to luteinizing hormone stimulus;8.0;1.0;0.875;9.628524252492122;601.1788189541068;8.67846133901236;0.020120914044583264;0.8188169164668168;[CCNA2, LHCGR]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, ARRB1, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, RIPK2, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, CD74, EGF, IGF1, MAPK14, BMP2, CD40LG, CDK1, CSPG4, PKN1]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[SPI1, EHMT2, SLA2, PHB2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, FZD1, JUN, PLK1, FZD8, NR2F2, PKIA, SNAI2, PKIG, EZH2, BTG2, CDKN1B, HELLS, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, ZEB1, TAL1, RARA, HCLS1, PLCB1, NR1I2, ASCL2, BTAF1, FLNA, STAT1, CDKN2A, NR1H2, NR1H4, POU4F1, CENPF, FOSB, LGR4, CSF2, GMNN, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, FOXO1, SBNO2, NACC2, ZNF423, WFS1, NFKB1, NFKB2, DAB2, BCL6, BCL3, CDK2, CIITA, FHL2, FASLG, FOXM1, HHEX, EMILIN1, RFC1, PEG3, XCL1, BIRC5, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, E2F8, PRRX1, KLF4, PML, KLF8, KLF5, DNAJA3, GFI1, IKZF1, UXT, ZNF608, EDNRB, DPF3, SOX7, SOX4, HNF1B, RUNX2, EREG, SFRP2, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H2, SUV39H1, IFNA2, PTPRK, BRCA1, BMI1, XPO1, CD38, CD36, HBZ, EDN1, NOG, PARP9, CBFA2T3, MDFIC, IL1B, DEPDC1, SP100, SATB2, RELB, PURA, RXRA, APBB1, CDX2, LILRB4, NEDD4, ARID4A, LOXL2, CHCHD3, BASP1, EOMES, CCNE1, TIMELESS, CALCA, TCF7, TGFB1, CBX4, VDR, CAV1, HMGA1, NR4A2, BMP2, NR4A3, UBA3, MXD1, CREBZF, HMGB2, MYOCD, KLF12, H2AFX, GREM1, RBL1, IFNG, ELF3, IRF7, IRF8, FBP1, PFDN5, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, GATA1, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, DLGAP5, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, STAT4, SPP1, STAT1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, RUVBL2, ADCYAP1, BLM, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, ARRB1, FOXM1, HHEX, PPP1R12A, PEG3, UHRF1, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, POU2AF1, CCNH, CCNC, IKZF1, TNFSF11, HNF1B, SFRP2, EGR1, EGR2, EGR3, IGF1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3D, HNF4A, CD38, IL10, IL18, RGMA, IL1A, IL1B, YAP1, SATB2, RELB, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, EOMES, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL2, MYBL1, YWHAH, MYOCD, DDX58, ETV1, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, RNF6, TBX21, EGF, MAPK14, CD4, TNIP3, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, PRKDC, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD2, FZD5, FZD8, FOSL2, FOSL1, TGFB1I1, PAX5, PAX2, ZEB1, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, EPCAM, NR1H2, NR1H4, GTF2H1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, DAB2, COPS5, MAFB, MAFF, BCL3, CDK2, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK2, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EDN1, NOG, RHOG, PARP9, MDFIC, TFEC, TLR4, TLR2, SP100, APBB1, CDX2, CDX1, LILRB1, GRHL2, CAMK4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, CKS1B, KLF13, CKAP2, DCN, DNM2, RBL1, LEF1, DLL1, S1PR1, LUM, MEIS2, MEIS1, RBMX]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[IHH, EDNRA, PDGFRA, TPM1, MSH2, TWIST1, GATA3, GATA1, EPB41L5, CCNB2, CCNB1, PLCG1, MYH10, STIL, EIF2S2, FOSL1, BMP2, MAFF, BCL2L1, PTPRR, TMEM100, HHEX, EDN1, DUSP3, NOG, RXRA, TIE1]
GO:0044320;cellular response to leptin stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;109.38485831558611;7.379178354882098;0.003661012767841448;0.7004918368257019;[CCNA2, PID1, NR4A3]
GO:0031915;positive regulation of synaptic plasticity;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;41.65758488823441;7.57984905034425;0.0013942418768168238;0.7626338329336335;[CDC20, PTGS2, EPHB2]
GO:0034501;protein localization to kinetochore;8.0;0.8436909121759173;0.7968454560879586;9.292052015870908;35.81813124301707;7.212124270218933;0.0011988006184784857;0.7438283705770736;[MIS12, CDK1, BUB1B, TTK, AURKB]
GO:0071930;negative regulation of transcription involved in G1/S transition of mitotic cell cycle;11.0;1.0;0.9324289523296623;9.628524252492122;1849.0626671205805;8.67846133901236;0.061886463420164586;0.8762458687964789;[E2F1, E2F7]
GO:2000111;positive regulation of macrophage apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;256.05226485460065;8.67846133901236;0.008569838872606032;0.8400575416471059;[MEF2C, CDKN2A, SIRT1]
GO:0031116;positive regulation of microtubule polymerization;10.0;0.8933024483968273;0.861892236059334;9.589303539338841;431.61701704611926;6.518977089658987;0.014445833130437288;0.7486218033895181;[CDKN1B, PAK1, PSRC1, FES]
GO:1903096;protein localization to meiotic spindle midzone;9.0;1.0;0.896240625180289;9.628524252492122;35.99248463016168;9.777073627680469;0.0012046360694383546;0.896240625180289;[TTK]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[, NUP107, DPYSL3, PRKACB, CLDN3, PADI4, PDGFC, ABCA1, MCTS1, JUP, FN1, COL1A1, COL1A2, HLA-DRB1, ACHE, DPYS, ARHGAP6, CHAF1B, CHAF1A, KCND2, ARG1, F5, SLC7A7, SLC7A9, KCNA5, CENPA, HLA-DMA, HLA-DMB, DMD, CENPW, CENPE, CENPF, CENPH, CENPI, CENPK, CENPL, CENPM, GOPC, CENPN, CENPO, KCNG2, NCF1, GMNN, RUVBL2, RUVBL1, OLFM4, BLM, UQCRB, LIN7A, ACAT1, G3BP2, CXCL12, DMXL2, HLA-DRA, LRRK2, ALAD, VBP1, NDUFC2, ACPP, BDP1, BIRC2, BIRC3, NDUFB7, NDUFB6, HM13, NDUFB4, NDUFB3, NDUFB2, NDUFB1, CDC45, CCL5, EIF4H, KCNJ2, NDUFA8, NDUFA7, NDUFA6, NDUFA3, NDUFA2, IL2RB, CD247, EIF3D, CCNH, PRF1, IKZF1, TCL1A, SNRPD2, SNRPD1, TNFSF11, FBXO5, SNRPD3, HNF1B, MIF, KCTD12, KCTD15, TGFA, PTK2, ANLN, CD40, CTSZ, CD3G, CD3E, CD3D, CCT3, CCT2, FCER1G, YAP1, NAPA, MIS12, CAPG, RXRA, CCT8, CD74, GCH1, RPA1, RPA2, RPA3, NDUFAB1, TGM2, NDUFB10, NDUFB11, TCF7, RASGRP1, CCNB1, LPXN, H1FX, ECT2, CAV2, UBE2C, CAV1, HMGA1, VIL1, NASP, UBE2S, TCF4, HMGB2, TNFAIP3, LAMC1, NUP62, GREM1, NDUFS8, NDUFS7, NDUFS6, NDUFS4, NDUFS3, NUP54, FBP1, TAF9, SAMHD1, RRM1, EGF, MX2, SOD2, TTC19, TEK, CDA, BIN2, ASF1B, NUP205, PRKCZ, ACMSD, HMOX1, NCKAP1L, EHD3, SERPINA1, CLINT1, TK1, BRD2, HCLS1, GSN, GTF2H1, HJURP, TNF, CLU, DACH1, OIP5, MEN1, TLE4, SNRPG, SNRPE, SNRPF, ITPR3, NACC2, LSM3, HOPX, SYNJ1, CDK1, PIK3C2A, PSTPIP1, EMILIN1, ADSL, VWF, TRAF1, PTBP2, MCM2, NLGN1, NLRC4, NOD2, PLN, WASF3, PML, MARCKS, RAD51, P2RX1, IMPDH2, PPP2R1A, MCCC2, COX7A2L, TLN1, MGST1, CD79B, CD79A, VASP, CDT1, AHCTF1, HBZ, RAD51C, UQCR10, AIF1, CTNNA1, NDUFA11, KNTC1, CHRNB4, NCF1C, ADRB2, NLRP3, MYH11, TGFB1, EIF2S1, H2AFX, AXIN2, CKAP5, DNM2, TGFBR3, COL6A2, COL6A1, COLEC12, CAMK2D, HIST1H2BK, LEF1, HSPD1, REPS2, POLQ, RBMX]
GO:0006296;nucleotide-excision repair, DNA incision, 5'-to lesion;8.0;1.0;0.875;9.628524252492122;115.13879119899096;6.166155715036245;0.0038535917232456105;0.6903374900225189;[PCNA, POLD3, POLD1, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA2, GTF2H1, RPA3]
GO:0036120;cellular response to platelet-derived growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.781341354126479;0.003262744749111514;0.6699184248047958;[PDGFRB, CCNA2, PDGFD, FYN]
GO:0030261;chromosome condensation;7.0;0.8259837884571596;0.7639112594857803;9.223059144383958;23.949217433387346;6.343086423195323;8.01558754599117E-4;0.6753050999230941;[TOP2A, CDCA5, NCAPG2, NCAPG, SMC4, NCAPH, SMC2, CDK1, NUSAP1, ACIN1, NCAPD2, NCAPD3]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK2, DOK3, RAB31, AGTR1, DNMT1, IQGAP3, RASGRP1, RRAS, G3BP2, JUN, HACE1, PLK2, DHCR24, IGF1, COL1A2, BCL6, CDK2, LAT, GPSM2, CDKN1A, ARHGAP6, ARHGAP4, RAC2, ARHGEF12, CHUK, RHOG, RHOH, RHOC, RAB33B, CCNA2, RHOU, AIF1, RAB21, PAK1, NRAS, PDPN, EPS8L1, EPS8L3, CDKN2A]
GO:0006297;nucleotide-excision repair, DNA gap filling;7.0;1.0;0.8509193652572005;9.628524252492122;149.0421272461911;6.641579411751319;0.0049883058697239;0.6905700452391912;[RFC5, RFC3, PCNA, RFC4, RFC1, LIG1, RFC2, RPA1, RPA2, POLD3, POLD1, RPA3]
GO:0006298;mismatch repair;8.0;0.8259837884571596;0.7879918942285797;9.500690880982237;183.0506323445446;6.375876246018314;0.006126539929698291;0.701062607729944;[PCNA, RNASEH2A, LIG1, RPA1, RPA2, MLH1, MSH6, POLD3, MSH2, EXO1, RPA3, PMS1]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[SMC3, AKT1, WDHD1, WDR76, PRKDC, CDCA5, RAD21, HMOX1, SFN, BARD1, LYN, MCTS1, PLK2, PLK1, CDC7, CDKN1A, BTG2, CDKN1B, CHAF1B, CHAF1A, CTLA4, ACTL6A, SIRT1, UNG, USP1, PMS1, GTF2H1, FMR1, TNF, PYCARD, RUVBL2, RUVBL1, MACROD2, MEN1, CDC25C, MSH6, MSH2, BLM, RNASEH2A, CUL5, FOXO1, RAD51AP1, MAP2K6, FANCI, FANCL, FANCG, COPS5, BCL6, CNOT3, BCL3, CDK2, CDK1, BCL2, BCL2L1, MCM7, MCM8, MCM10, FOXM1, EXO1, TLK1, RFC5, RFC3, RFC4, RFC1, RFC2, SMC1A, TNFRSF1B, TFDP1, DTL, PPP1R15A, UHRF1, CDC45, RBBP8, POLR2E, E2F1, POLR2I, POLR2J, E2F7, POLR2K, POLR2L, E2F8, DONSON, MND1, PML, RAD50, RAD51, MNDA, SMARCAL1, CCNH, CHEK2, CHEK1, TRIM25, SOX4, TIPIN, ESCO2, MIF, NEIL3, DNA2, EPHA2, BRIP1, POLA1, ATR, TOP2A, FEN1, SUV39H1, BRCA1, BRCA2, PARP9, RAD51C, SGK1, YAP1, SP100, PCNA, RAD54B, RAD54L, APBB1, GINS2, GINS4, RPA1, RPA2, MLH1, RPA3, NEDD4, TRIP13, DCLRE1A, PTTG1, LIG1, FANCD2, TIMELESS, PSMD14, CCNB1, CLSPN, HMGA1, ISG15, UBE2T, JMY, CASP2, TOPBP1, H2AFX, MASTL, RBL2, IRF7, BCL2A1, TAF9, AURKA, POLD3, POLD1, POLQ, MAPK14, POLE2]
GO:0046626;regulation of insulin receptor signaling pathway;6.0;0.7980440201809971;0.722142322680643;9.260799472366804;66.92878063041714;5.8067817141283475;0.002240046055708086;0.6200793994936333;[PID1, SLA2, PRKCZ, GNAI2, SOCS2, SESN3, CISH, PRKCB, PRKCD, NR1H4, TSC2, SIRT1, PTPRE, RPS6KB1, CDK4, IL1B, PRKCQ]
GO:0006975;DNA damage induced protein phosphorylation;8.0;1.0;0.875;9.628524252492122;212.05375489921127;7.697632086000634;0.007097248340487313;0.7686572628545723;[CHEK2, CHEK1, MAP2K6]
GO:1904628;cellular response to phorbol 13-acetate 12-myristate;6.0;1.0;0.8231203125901445;9.628524252492122;206.53951326657835;8.390779266560578;0.006912691635538367;0.7522251544931926;[MAP4K1, CDK4]
GO:1903416;response to glycoside;4.0;0.7866048967936545;0.6433024483968273;8.840066892127851;27.321196622860832;8.16763571524637;9.144158634865458E-4;0.6676932703116032;[ABCB4, CHEK2]
GO:0051412;response to corticosterone;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;159.4387911184404;6.7325511899570465;0.0053362728531380675;0.719302980950052;[FOSL1, CDKN1A, FOSB, AVPR1A, FOS]
GO:0000077;DNA damage checkpoint;8.0;0.811012628672052;0.780506314336026;9.456673995565463;85.75736069739153;5.486614186532078;0.002870221685927797;0.655585704652903;[BLM, BRIP1, CHEK2, CHEK1, E2F1, TOPBP1, CLSPN, FANCI, TIPIN, H2AFX, DONSON, RPA2, MAPK14, MSH6, MSH2, CDK2, CDK1, ATR]
GO:0071480;cellular response to gamma radiation;7.0;1.0;0.8509193652572005;9.628524252492122;60.39874674087868;6.444869117505266;0.0020214916980741903;0.6805102716434839;[YAP1, EGR1, CDKN1A, H2AFX, CHEK2, NOX4, BCL2L1, ATR]
GO:0000076;DNA replication checkpoint;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;54.456905800140625;6.8867018697843045;0.0018226236290973575;0.7271862538851576;[CDT1, TIPIN, CDC45, TIMELESS, CDC6, TOPBP1, NAE1, CLSPN, DNA2]
GO:0001953;negative regulation of cell-matrix adhesion;7.0;0.8653626801206646;0.7836007053175329;9.387362195675234;66.9585131603638;6.280566066213989;0.002241041176727861;0.6721078059595746;[POSTN, JAG1, CDKN2A, SERPINE1, ARHGAP6, THBS1, BCL6, DLC1, HOXA7]
GO:0072332;intrinsic apoptotic signaling pathway by p53 class mediator;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;80.0523555558605;5.734022359845919;0.002679280298012042;0.64415753539903;[CDKN1A, BRCA2, PYCARD, PERP, CHEK2, TP53BP2, E2F1, E2F2, SIRT1, POU4F1, PML, MSH2, JMY, BCL3]
GO:0071364;cellular response to epidermal growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.088194173566533;0.003262744749111514;0.63447084575632;[MCM7, AKT1, PLCG1, MED1, CAD, PAX2, COL1A1, VIL1, ID1, SNAI2]
GO:0048255;mRNA stabilization;10.0;0.8933024483968273;0.861892236059334;9.577230958104572;1968.7172834448895;6.088194173566533;0.06589119574637584;0.7265915450270957;[RBM38, SLC11A1, AXIN2, MAPK14, E2F1, MYD88]
GO:0000070;mitotic sister chromatid segregation;6.0;1.0;0.8231203125901445;9.628524252492122;56.84344269090966;6.311337724880743;0.0019024988710876387;0.6458824173477649;[SPAG5, MIS12, PLK1, CDCA8, SMC1A, TUBG1, SMC4, ZWINT, NDC80, KIF18A, KIF18B, ESPL1, KIFC1, NUSAP1, NEK2, RAN, MAD2L1]
GO:2000002;negative regulation of DNA damage checkpoint;8.0;0.8933024483968273;0.8216512241984136;9.577230958104572;225.4393771721141;8.16763571524637;0.007545253071683436;0.7926932703116032;[CHEK2]
GO:0033762;response to glucagon;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;6.166155715036245;0.0024778305216419678;0.6662568552797195;[ARG1, ABCB4, GLP2R, CCNA2, ADCY9, PRKAR1B, RPS6KB1, PRKAR2B, CYC1, PRKACB]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[CDKN1A, CEBPB, PCNA, C5AR1, IHH, ADM, TYMS, AURKA, ATIC, HMOX1, IL10, MED1, TGFB1, ANXA3, CAD, SULF2, TGFBR3, NFKBIA, CCNA2, CXCL12, NR4A3, CDK4, CDK1, LCP1, EZH2]
GO:0032436;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;11.0;0.8259837884571596;0.845420846558242;9.498471124243924;3778.5456327194074;5.334422371190153;0.12646452185682636;0.705231560468336;[LRRK2, CLU, AKT1, CBFA2T3, RNF144A, RNF144B, TRIB1, CEBPA, AURKA, IL33, PLK2, CAV1, PLK1, DAB2]
GO:0090435;protein localization to nuclear envelope;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;34.85305034697331;7.697632086000634;0.0011665002294043187;0.7445766281117727;[NUP155, PLK1, NUP54]
GO:0006260;DNA replication;7.0;0.7307253602413294;0.7162820453778652;9.271849308553389;254.20053156235352;4.77312732173501;0.008507863025766288;0.5950173184638491;[DSCC1, CHEK1, WDHD1, DNA2, SLBP, BLM, RNASEH2A, BRIP1, CLSPN, BARD1, CDT1, CDC7, CDC6, POLA1, POLA2, NASP, CDK2, CDK1, ATR, ACHE, FEN1, MCM7, MCM8, MCM10, BRCA1, CHAF1B, CHAF1A, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, RMI1, DBF4, MCM3, MCM4, MCM5, MCM6, DTL, MCM2, CDC45, POLD1, RBBP8, POLQ, RRM1, RRM2, RPA1, DONSON, RPA2, RAD50, POLE2, RPA3, DNAJA3, SSBP1]
GO:1900034;regulation of cellular response to heat;6.0;0.8653626801206646;0.7558016526504768;9.271849308553389;29.43425144606613;5.970411137910149;9.851379067933503E-4;0.6284474158353811;[CD34, RPA1, RPA2, SIRT1, RPA3, ATR]
GO:0048812;neuron projection morphogenesis;7.0;0.6547035408479693;0.6782711356811852;8.502512989635898;62.99970935475633;4.360973225476049;0.002108543576046295;0.5739397388140403;[ADARB1, STMN1, EPHB2, EPHB1, MNX1, MEF2A, MAP1B, KIF20B, NBL1, SDC2, EPB41L3, NCKAP1L, GP5, PTK2, NR4A2, LRFN4, OGN, BCL2, NRP1, LRRK2, RAC2, DCC, STRADB, PAX2, DNM2, CDH11, SGK1, DSCAML1, SHANK3, NLGN1, LRP2, PAK1, NTF3, SLITRK6, FYN, APBB1, LINGO1, SEMA4A, POU4F1, WEE1]
GO:0045787;positive regulation of cell cycle;5.0;0.5265193887476639;0.5535007062347522;7.230628979693751;42.184038669436575;3.8238302933926853;0.0014118618110960173;0.4857918708913159;[, CCNH, CCNF, CCNC, PHB2, CHEK2, CHEK1, AKT1, SOX4, MED1, PRKCE, TAS2R13, FLT3LG, MIF, EREG, BTC, KIF20B, CDCA5, TGFA, RACGAP1, RAD21, SFN, PLK4, CDT1, PLK2, CDC7, CDC6, IGF1, FOSL1, CD28, CDKN1A, FEN1, BTG2, CDKN1B, KIF14, BRCA1, BRCA2, DLGAP5, IL10, EDN1, ANXA1, DUSP3, KIF23, CIT, IL1A, RAD51C, TAL1, IL1B, CKS2, RARA, PLCB1, PCNA, CXCR5, KCNA5, AIF1, RANBP2, RANBP1, SVIL, POU4F1, FAP, MAD2L1, CCNT2, CEP120, CTGF, NUSAP1, PDGFRB, CDC25C, CDC25A, CCNE2, CCNE1, CCNB2, CCNB1, ECT2, FAM83D, TGFB2, TGFB1, UBE2C, NDC80, NR4A3, CDK4, CNOT3, CDK2, CDK1, GPSM2, CKS1B, NUP62, CASP2, CCNA2, RBL2, PSRC1, TFDP1, ESPL1, DTL, SMARCD3, VPS4B, AURKB, AURKA, CDC45, E2F1, POC1A, E2F7, SH2B1, E2F8, SPAG5, EGF, MEIS2, PML, RPS6KB1, EVI2B]
GO:0042276;error-prone translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.7325511899570465;0.025467164394386097;0.7595439928109722;[RFC5, RFC3, PCNA, RFC4, RFC1, RFC2, RPA1, RPA2, POLE2, RPA3]
GO:0006267;pre-replicative complex assembly involved in nuclear cell cycle DNA replication;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;77.92043580405796;8.67846133901236;0.0026079268625224215;0.8400575416471059;[CDC45]
GO:0006268;DNA unwinding involved in DNA replication;8.0;0.8259837884571596;0.7879918942285797;9.34084218004034;24.41922106263308;7.57984905034425;8.172893530941673E-4;0.7626338329336335;[PURA, RAD51, MCM7, HMGA1, RPA1, MCM4, MCM6, MCM2]
GO:1904637;cellular response to ionomycin;7.0;1.0;0.8509193652572005;9.628524252492122;445.380901097022;8.390779266560578;0.014906497942929567;0.7800242071602487;[CDK4]
GO:0006813;potassium ion transport;7.0;0.7980440201809971;0.7499413753476991;9.310070521373587;34.16983994150393;4.61801832846594;0.001143633791982704;0.587085037334763;[KCNK5, KCNG2, CDKN1B, AQP1, KCNH1, KCNH2, KCND2, ATP1B2, ATP1B1, KCNQ1, SLC24A2, SLC24A4, KCNE3, KCNE4, VPS4B, SLC1A3, KCNA5, KCNMB3, KCNN3, KCNJ2, SLC12A2, SLC12A1, KCNIP4, KCNJ15, KCNJ16, FXYD2, CDK2]
GO:2000816;negative regulation of mitotic sister chromatid separation;10.0;0.811012628672052;0.8207473261969463;9.507163395487854;941.8965548825082;6.599019797332524;0.03152443004005238;0.7527151911823093;[PLK1, BUB1B, TTK, CENPF, PTTG1, RAD21, TRIP13, BUB1, MAD1L1, PTTG3P, MAD2L1]
GO:0071392;cellular response to estradiol stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;338.1710882258028;6.221725566191056;0.011318281988697268;0.6412996473849828;[IL10, ABCB4, POU4F1, CCNA2, KIF18A, RUVBL2]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, HDAC2, PTGS2, THBS1, HMOX1, LYN, HSPA6, MYOF, EIF2S1, CXCL10, IL1A, TFEC]
GO:0071398;cellular response to fatty acid;6.0;0.7369933605727446;0.6916169928765168;9.004369943419128;203.00017448222317;5.8067817141283475;0.006794233151624104;0.6200793994936333;[PID1, PTGER2, PTAFR, TNC, P2RY6, CCNB1, E2F1, AKT1, FFAR2, PTGDR, EDN1, DGAT2, PRKCE, NR1H4, AKR1C3, NME1, CDK4, IL1B]
GO:0045793;positive regulation of cell size;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;29.63014819255531;7.379178354882098;9.916943946027175E-4;0.7004918368257019;[EDN1, CDK4]
GO:0071157;negative regulation of cell cycle arrest;7.0;1.0;0.8509193652572005;9.628524252492122;127.41368125290029;6.641579411751319;0.004264421246666119;0.6905700452391912;[MIF, CDK4, CHEK2, EVI2B]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, JUNB, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, JAK3, HLA-DPA1, ANXA1, SERPINB2, IFNGR1, GPR35, RIPK2, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, ZEB1, PLCB1, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, STAT1, IL10RA, HLA-DPB1, PF4, CSF3, CSF3R, CSF2, F13A1, IL5RA, RORA, CXCL13, TNF, PYCARD, IGHG1, MAP3K8, IL13RA2, IL13RA1, IFNA14, CISH, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, CD300LF, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, BCL2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, PIK3CD, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL2, XCL1, BIRC5, LCP1, BIRC2, BIRC3, CX3CR1, CEBPA, CEBPD, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, IL21R, CCL2, CCL1, FYN, FCGR1A, FCGR1B, PML, KLF6, IL2RA, IL2RB, PTPN6, IL1RN, IFITM1, IFI30, IFIT1, IFIT3, IFIT2, ICAM1, TNFSF11, TRIM25, IL15RA, RSAD2, ACSL1, IL1R1, IL1R2, HLA-B, FLT3LG, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IFI27, IL23A, EBI3, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, CD27, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, IL10, SYK, IL15, IL18, GP1BA, GAB2, IL17RB, VAV1, HCK, IL1A, CEACAM1, IL1B, KIT, RHOU, SP100, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR3, CXCR2, IL32, CD74, IL33, OSM, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, ISG15, NFKBIA, IL6, IL7R, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, LMNB1, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, AIM2, IFNG, OAS1, OAS3, LTA, IRF7, IRF8, LTB, CAMK2D, SAMHD1, S1PR1, NCAM1, MX2, SOD2, CD4, LTBR]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, PRKDC, PDGFA, BMI1, AQP1, CCNB1, PDGFD, MYB, PDGFC, E2F1, PDGFRB, PDGFRA, CD74, JUN, TGFB1, FN1, CDC6, MIF, IGF1, PML, EREG, FOSL2, BTC, CCNA2, CDK6, CDK4, NDUFS4]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[BRCA2, CENPA, RACGAP1, STMN1, NUSAP1, ECT2, MYH10, CEP55, CDT1, PLK1, CKAP2, KIF23, RHOC, CIT, ANLN, ESPL1, KIF4A, KIF20A]
GO:2000134;negative regulation of G1/S transition of mitotic cell cycle;9.0;0.7980440201809971;0.7952626352707877;9.394909401310617;355.88113835876356;5.244474134527214;0.011911021428637128;0.6644432763129993;[CDKN1A, BTG2, CDKN1B, CHEK2, CASP2, SOX4, CDC25C, RBL2, TFDP1, RBL1, PCNA, PRKDC, AURKA, CCNB1, GPNMB, NACC2, E2F1, CCL2, SFN, E2F7, E2F8, PLK2, RPA2, KLF4, PML, CNOT3, CDK2, CDK1, BCL2, EZH2]
GO:0051307;meiotic chromosome separation;4.0;0.8653626801206646;0.6826813400603323;9.223059144383958;35.562483153567804;8.67846133901236;0.0011902443069929621;0.6938169164668168;[BLM, ESPL1]
GO:0010870;positive regulation of receptor biosynthetic process;7.0;0.8436909121759173;0.7727648213451592;9.466005322994347;258.61903890750995;7.379178354882098;0.008655746490210232;0.728290889492758;[EDN1, HDAC2, HOXA5]
GO:2000379;positive regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;112.71770282919289;5.299736813202263;0.0037725600743465397;0.5941490996802742;[CDKN1A, PID1, ITGAM, ITGB2, TNF, CLU, ICAM1, AKT1, CD36, CD177, PDGFRB, EDN1, PRKCD, DNM2, IFNG, IL1B, AGTR1, TLR6, TLR4, FPR2, PTGS2, THBS1, AIF1, GNAI2, KLRK1, SNCA, TGFB1, AGXT2, AKR1C3, MAPK14, KLF4, NOX4, F2RL1, PTX3]
GO:0070987;error-free translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.781341354126479;0.025467164394386097;0.7620391240755716;[RFC5, RFC3, PCNA, RFC4, RFC1, RFC2, RPA1, RPA2, RPA3]
GO:0006270;DNA replication initiation;7.0;0.7980440201809971;0.7499413753476991;9.405380701177911;149.0421272461911;6.343086423195323;0.0049883058697239;0.6753050999230941;[GINS2, MCM7, MCM8, GINS4, MCM10, CDC7, CDC6, POLA1, PURA, POLA2, CDC34, CDC45, CCNE2, CCNE1, MCM3, MCM4, MCM5, MCM6, TOPBP1, MCM2]
GO:1903671;negative regulation of sprouting angiogenesis;9.0;0.8653626801206646;0.8289219652406215;9.456673995565463;200.36531453095495;6.599019797332524;0.00670604676027516;0.7337148045016781;[SEMA6A, KLF4, THBS1, E2F2]
GO:0048709;oligodendrocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;23.145667324477426;6.518977089658987;7.746646556020492E-4;0.623621803389518;[CDKN2C, DUSP10, TSPAN2, CSK]
GO:0070979;protein K11-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;6.375876246018314;0.00527474598481953;0.7584915600596062;[ANAPC10, CDC23, UBE2C, UBE2S, UBE2T]
GO:0000727;double-strand break repair via break-induced replication;10.0;1.0;0.9152410118609203;9.628524252492122;521.7226431472901;8.16763571524637;0.01746158734624478;0.8329342821725234;[GINS2, CDC45, GINS4, CDC7]
GO:0031571;mitotic G1 DNA damage checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;856.0185997856339;7.474488534686424;0.0286501721681018;0.8146746435927894;[CDK2, RPA2]
GO:1904884;positive regulation of telomerase catalytic core complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;140.3817219977405;9.083926447120524;0.004698449899916962;0.8154717862087246;[ATR]
GO:0006272;leading strand elongation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;265.91551950056737;8.67846133901236;0.008899953129253659;0.8400575416471059;[POLA1, PCNA]
GO:0000723;telomere maintenance;7.0;0.7307253602413294;0.7162820453778652;9.292052015870908;183.01793442924338;5.266214121163619;0.006125445559899373;0.6202338003175094;[DCLRE1A, FEN1, BRCA2, RFC5, RFC3, RFC4, RFC1, RFC2, RAD51C, CCNE2, CCNE1, DNA2, PRIM2, BLM, SP100, PCNA, PRKDC, PRIM1, POLD3, POLD1, RPA1, RPA2, POLA1, POLA2, RAD50, RAD51, RPA3]
GO:0007129;synapsis;6.0;1.0;0.8231203125901445;9.628524252492122;47.18392532465019;6.686031174322154;0.0015792035178401665;0.665044257777226;[CCNE2, CCNE1, FANCD2, MLH1]
GO:0046890;regulation of lipid biosynthetic process;6.0;0.5023590972498763;0.5742998612150827;7.07462473121717;29.090713891559723;4.6590798152637145;9.736400140077473E-4;0.5613858710120996;[GFI1, TNF, AKT1, DGAT2, PRKCD, POR, SIK1, PDGFA, FPR2, C3, IGFBP7, EGR1, VDR, NFKB1, BMP2, CDK4, SNAI2, BRCA1, CYR61, ANXA1, ELOVL6, AVPR1A, SIRT1, CEACAM1, IFNG, IL1B, PTGS2, NR1H2, NR1H4, AKR1C3, SORBS1, SCD, RAN]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, AKT1, CASP2, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, KCNJ2, CASP8AP2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:1990314;cellular response to insulin-like growth factor stimulus;8.0;1.0;0.875;9.628524252492122;388.66587636398185;7.57984905034425;0.013008297105323164;0.7626338329336335;[CCNA2, GHSR, TGFB1, FBN1]
GO:0001933;negative regulation of protein phosphorylation;9.0;0.6056485694559711;0.6990649099082746;8.75603614327636;664.693789818838;3.7392027077583316;0.02224670295966317;0.5874636255457587;[PID1, ADARB1, PPP2R1A, AKT1, EPHB2, PAQR3, PRKCD, SFRP2, PRKAR1B, TRIB1, ATF3, PRKDC, TWIST1, THY1, PRKCZ, SAMSN1, FLRT2, PRKAR2B, SFN, LYN, JUN, GADD45B, PLK1, LIF, NR2F2, PKIA, CALM3, PKIG, CDKN1A, PTPRR, CDKN1B, LRRC4, PBK, TIMP3, DUSP2, DUSP3, DUSP1, NOG, BGN, GP1BA, SIRT1, DUSP6, CEACAM1, IL1B, TLR4, ENG, LRRC19, FAM129A, NTF3, DMD, CDKN2C, CDKN2A, PODN, NLRP12, F2RL1, PKN1, PYCARD, MEN1, CISH, CD300A, IGFBP3, TSC2, FBLN1, FOXO1, SOCS2, CCNB1, TGFB1, CAV1, PTPRC, CDK6, CDK4, GNAQ, LRRK2, TNFAIP3, PTPN22, ARRB1, ARRB2, FOXM1, HHEX, DUSP10, LRRTM4, NUP62, EMILIN1, MYOCD, PDE4D, IRAK3, DCN, GREM1, ZMYND11, CEBPA, CSK, SNCA, KLF4, PTPN6]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[, PHB2, AKT1, PROK2, PRKACB, PRKCE, PRKCD, PRKAR1B, FPR1, PDGFA, FPR2, SLC30A10, IQGAP3, GATA1, PRKCZ, C3, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, PLK1, FZD8, EIF2AK2, CDC6, AZU1, NOX4, NOX1, EZH2, CDKN1A, CDKN1B, TIMP2, HAVCR2, GPR37, RIPK2, FCRL3, EMP2, SIRT1, DUSP6, CKS2, HCLS1, PLCB1, HBEGF, ENG, CCL13, FAM129A, PTGS2, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, CENPE, PKN1, CSF3, CCNT2, CSF2, NCF1, FMR1, TNF, CLU, CTGF, PYCARD, MAP3K8, IFNA14, MAP2K2, IFNA16, IGFBP3, F2R, ADCYAP1, ADAM9, ADAM8, IFNA10, CSF1R, TNFRSF11A, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, DAB2, PTPRC, CDK1, BCL2, CSPG4, LAT, LRRK2, ITGB3, TREM2, PTPN22, ARRB1, ARRB2, CYR61, XCL2, XCL1, LCP2, HDAC2, TTK, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, RAD50, FCGR2B, IL1RN, CCNH, CCNC, ICAM1, TCL1A, EDNRB, CHEK2, TNFSF11, EPHB2, EPHB1, ACSL1, SLC11A1, FLT3LG, MIF, EREG, SFRP2, IL23A, EPHA3, EPHA2, TGFA, PIK3R5, SLAMF1, CCR1, EGR1, GADD45B, LIF, IGF1, PTK2, MARCO, TPX2, CD27, CALM3, CD24, IFNA5, IFNA4, NRP1, IFNA7, CD40, IFNA2, KIF14, CD3E, IFNA8, CCR7, CD36, MAP4K1, EDN1, SYK, IL15, STRADB, IL18, PARP9, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CXCR4, AIF1, GNAI2, PAK1, CD74, OSM, CD40LG, F2RL1, CAMK1, CD80, IL6R, PDGFRB, PDGFRA, CALCA, C5AR1, ADRB2, RASGRP1, CCNB1, STAP1, CLSPN, ECT2, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, CKS1B, GHR, GRM5, PLAUR, AXIN2, MMP9, GREM1, PSRC1, IFNG, CHI3L1, PDE5A, LTF, THBS1, SNCA, EGF, MAPK14, CD4, LTBR, TEK]
GO:0031442;positive regulation of mRNA 3'-end processing;10.0;0.9326813400603323;0.8815816818910864;9.590783924509275;630.6357977915417;7.57984905034425;0.021106812616712402;0.8028748447945538;[CCNB1, NCBP2]
GO:0010767;regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage;12.0;0.9326813400603323;0.9144609826203107;9.60185600540996;631.9844254116175;8.67846133901236;0.02115194996947028;0.8919372290569614;[NEDD4, CHEK1]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1A, CDKN1B, DUSP1, STRADB, MSH2, IFNG, RRAGD, GAS1, KIF20B, PPP1R15A, CUL5, THBS1, APBB1, GAS2L1, MAP2K6, BARD1, TGFB2, TGFB1, CDKN2C, CDKN2A, DHCR24, INHBA, PML, CDK6, FAP, JMY, CDKN3]
GO:0030071;regulation of mitotic metaphase/anaphase transition;10.0;0.7586651285174919;0.7945735761196663;9.405380701177911;262.3324330841205;5.885253329569843;0.0087800304514636;0.7162131408273906;[BUB1B, TTK, CCNB1, CDC23, RAD21, BUB1, DLGAP5, CDT1, DUSP1, UBE2C, PLK1, CDC6, NDC80, CENPE, CENPF, ESPL1, TRIP13, MAD1L1, MAD2L1]
GO:0045727;positive regulation of translation;8.0;0.6634067003016617;0.7067033501508309;9.123968241739727;1032.6861465930526;5.104244793218563;0.03456307596927652;0.6360313160968547;[FMR1, TNF, SOX4, PPP1R15A, PTAFR, FAM129A, THBS1, RXRA, CCL5, UPF3B, IL6, LIN28A, RPS6KB1, CDK4, BCL3, CD28, EIF3E, EIF3D]
GO:1902990;mitotic telomere maintenance via semi-conservative replication;9.0;1.0;0.896240625180289;9.628524252492122;232.51800064843582;8.67846133901236;0.007782168229088393;0.8400575416471059;[PCNA, DNA2]
GO:0007052;mitotic spindle organization;7.0;0.8259837884571596;0.7639112594857803;9.280217558223907;96.21539173928952;5.486614186532078;0.0032202425732832385;0.6315050699101035;[GPSM2, TTK, KIF11, AURKB, AURKA, CDC20, CCNB1, CHEK2, STMN1, NUF2, POC1A, FLNA, NEK2, MYBL2, STIL, PLK2, TUBG1, NDC80, CENPE, TPX2, KIFC1, KIF4A, BIRC5, RAN, BIRC2, SPC25, BIRC3]
GO:0036297;interstrand cross-link repair;8.0;0.8933024483968273;0.8216512241984136;9.541512875502493;183.0506323445446;5.905872616772578;0.006126539929698291;0.6770266002729131;[DCLRE1A, RAD51AP1, FANCI, FANCL, RPA1, RPA2, FANCG, MSH6, RAD51, MSH2, FANCD2, RPA3, UBE2T, ATR]
GO:0045841;negative regulation of mitotic metaphase/anaphase transition;11.0;0.8436909121759173;0.8542744084176208;9.5544162803384;1557.3872016210385;6.7325511899570465;0.052124348080771515;0.7767319332797141;[PLK1, BUB1B, TTK, CENPF, RAD21, TRIP13, BUB1, MAD1L1, MAD2L1]
GO:0045842;positive regulation of mitotic metaphase/anaphase transition;11.0;0.9326813400603323;0.8987696223598284;9.60254876608886;1435.6381372244598;7.57984905034425;0.04804951646246229;0.8200627852632958;[CDT1, ESPL1, DLGAP5]
GO:0050994;regulation of lipid catabolic process;6.0;0.6369964171292115;0.6416185211547503;8.17323701988528;28.336942089180127;5.845247994956144;9.484119501326822E-4;0.6220465668840318;[TWIST1, TNF, CNR1, AKT1, PRKCE, PRKCD, FABP1, CDK4, IL1B, LGALS12]
GO:0032922;circadian regulation of gene expression;6.0;1.0;0.8231203125901445;9.628524252492122;31.18462308171688;5.769740442447999;0.0010437212702063816;0.618185107137305;[HDAC2, RORA, RELB, HNF1B, SIRT1, PML, PPP1CA, MC3R, LGR4]
GO:0043550;regulation of lipid kinase activity;9.0;0.7369933605727446;0.7647373054666613;9.292052015870908;63.107251229778875;5.825829909099042;0.0021121429058218954;0.694173837660411;[PIK3R3, FPR2, NOD2, PIK3R5, CCR7, CCL19, LYN, PDGFRB, PDGFRA, TGFB1, CCL21, KLF4, PTK2, FGR, RBL2, RBL1, KIT, TEK]
GO:2000278;regulation of DNA biosynthetic process;7.0;0.6913464685778243;0.6965925995461126;9.040737587590003;150.73814970462044;5.152100814396198;0.005045070215086414;0.6143980405026119;[CDKN1A, DSCC1, ARRB2, DACH1, NEK2, MEN1, RFC5, PDGFRB, CCT3, CCT2, RFC3, RFC4, DUSP1, RFC2, GREM1, PRKCQ, AURKB, CCT8, CCT7, CCT5, SH2B1, CCT4, NEK7, KLF4, GRHL2, CCT6A, NOX4, ATR]
GO:0072425;signal transduction involved in G2 DNA damage checkpoint;9.0;0.9326813400603323;0.8625812952104552;9.590783924509275;196.6208089386036;7.292166977892469;0.006580721527935406;0.769162383550154;[CHEK1, PLK1, BRCA1, DTL]
GO:0016572;histone phosphorylation;8.0;0.7090535922965819;0.729526796148291;9.195660170195843;367.80445225036385;6.444869117505266;0.012310084014303157;0.7045909063862833;[PRKCB, PRKCD, VRK1, AURKB, AURKA, CCNA2, CCNB1, CHEK1, CDK2, CDK1, PKN1]
GO:0072423;response to DNA damage checkpoint signaling;6.0;0.8436909121759173;0.7449657686781032;9.36615998802463;39.35639663538549;7.9853141584524145;0.0013172231769289413;0.7314896500084853;[SMC1A]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[SUV39H2, SUV39H1, MPL, RORA, PHB2, SLC8A1, AQP1, ICAM1, AKT1, EDN1, KCND2, PRKCE, SIRT1, CCNA2, ADAM8, TWIST1, PTGS2, CCNB1, BRIP1, E2F1, HMOX1, FABP1, BCL2]
GO:0033574;response to testosterone;5.0;0.9326813400603323;0.7565816818910864;9.533214072687796;91.03892825708995;6.063501560976162;0.003046990999048697;0.6003287636709002;[THBS1, PLN, SPP1, EDN1, DUSP1, CAD, NME1, NASP, RPS6KB1, CDK4]
GO:0072428;signal transduction involved in intra-S DNA damage checkpoint;12.0;1.0;0.9481203125901445;9.628524252492122;1644.1433708141308;9.777073627680469;0.05502799898818113;0.9481203125901445;[CHEK2]
GO:0045739;positive regulation of DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.360260265897443;499.6181899148078;5.8650506222523235;0.01672177118926996;0.6749389615747303;[BLM, PCNA, BRCA1, FOXM1, APBB1, H2AFX, PARP9, SIRT1, TIMELESS]
GO:0007062;sister chromatid cohesion;5.0;0.7508913569872202;0.6656866903545304;8.801845679307654;32.565640385727406;6.113511981550823;0.001089942676536732;0.6028862989048107;[CDCA5, PLK1, BUB1B, ESCO2, SMC1A, SMC3, PHB2, CDC20, RAD51C, STAG2, PPP2R1A, RAD21, BUB1]
GO:1904385;cellular response to angiotensin;8.0;1.0;0.875;9.628524252492122;462.69925393661634;7.379178354882098;0.015486127626965131;0.7523715242355574;[BRIP1, PRKCD, CDC6, SLC30A10, NFKB1]
GO:0045737;positive regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2922.0785093664276;6.193554689224359;0.09779933800857048;0.7648589874268262;[CCNT2, CDKN1B, CCNH, CCNC, CKS1B, CCNB1, AKT1, CDC6, PSRC1, CKS2]
GO:1901673;regulation of mitotic spindle assembly;10.0;1.0;0.9152410118609203;9.628524252492122;218.77880646863287;6.832634648514029;0.0073223297643623805;0.7646622655359331;[VPS4B, PLK1, SMC1A, SMC3, STAG2]
GO:0007063;regulation of sister chromatid cohesion;8.0;0.6260725219892441;0.688036260994622;8.694215015115288;54.93577305356617;6.686031174322154;0.0018386508851169624;0.7169239451870815;[FEN1, CDCA5, AXIN2, ESPL1, RAD21, BUB1]
GO:0007064;mitotic sister chromatid cohesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;49.163113097731234;7.212124270218933;0.0016454451514518356;0.6919486831672181;[CDC20, CDCA5, SMC1A]
GO:1901796;regulation of signal transduction by p53 class mediator;7.0;0.7192862368539868;0.710562483684194;9.117698628726131;45.070113835906206;4.948759890378168;0.001508456149618737;0.6039991761920099;[CHEK2, CHEK1, AKT1, MIF, SIRT1, TAF9, TWIST1, AURKB, AURKA, TP53BP2, CD74, MAPK14, POU4F1, PML, TPX2, JMY, CDK2, SNAI2, TAF5, ATR]
GO:0042220;response to cocaine;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;106.24722930474235;6.343086423195323;0.0035559991485312878;0.647506047256038;[CCNA2, HDAC2, CNR1, TACR3, DNM2]
GO:0045732;positive regulation of protein catabolic process;7.0;0.7043150770688792;0.7030769037916401;9.033817144745429;231.0521549826792;4.39257856489138;0.0077331076938309705;0.5755560373415389;[FMR1, TNF, CLU, AKT1, ADAM9, ADAM8, TRIB1, NEDD4L, FOXO1, BARD1, OSBPL7, PLK2, TNFSF12, CAV1, PLK1, PTK2, DAB2, CCDC22, CDKN1B, LRRK2, TNFAIP3, TNFRSF1B, CBFA2T3, RNF144A, RNF144B, IFNG, IL1B, DTL, CEBPA, LRP1, LRP2, AURKA, IL33, EGF, PSMC6, NEDD4, PSMC2]
GO:0043433;negative regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.468181602416943;278.0076986152632;4.753193106834193;0.00930466748196786;0.6755074688592472;[GFI1, TNFAIP3, ARRB1, ARRB2, PHB2, PYCARD, CYP1B1, HAVCR2, MEN1, IL10, CHUK, IRAK3, SIRT1, SFRP4, AIM2, XCL1, SIK1, TRIB1, SP100, HDAC2, TWIST1, NLRC3, PKHD1, G3BP2, FLNA, NLRP3, HMOX1, WFS1, CDKN2A, NR1H4, KLF4, NFKBIA, NLRP12, ID1, CCDC22, NFKBID, EZH2, FOXA2]
GO:0008156;negative regulation of DNA replication;8.0;0.7090535922965819;0.729526796148291;9.223059144383958;828.3435142391211;6.113511981550823;0.02772391196081998;0.6876452870438905;[SMARCAL1, BLM, GMNN, BRCA2, SMC3, CHEK2, S100A11, TIPIN, DONSON, CDC6, SMC1A, MSH6, STAG2, MSH2, BCL6, TIMELESS, ATR]
GO:1904706;negative regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.8833163751231;6.8867018697843045;0.0027070918088165762;0.7031056191423581;[IL10, CNN1, MEF2C, CDKN1A, MYOCD, CDKN1B, TPM1, HMOX1, SOD2]
GO:0045736;negative regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2927.1185870500644;6.375876246018314;0.09796802487286638;0.7741829203200885;[CEBPA, CDKN1A, MYOCD, CDKN2C, CDKN1B, CDKN2A, PLK1, TNFAIP3, NR2F2, HHEX, CDK6, CDK4, MEN1]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[CYFIP1, SPARC, CTGF, ICAM1, EDNRB, SESN3, AKT1, PRKACB, MEN1, GHSR, LHCGR, IGFBP5, PRKCD, CYBB, EREG, POR, ADCY9, RAB31, PRKAR1B, PRKDC, ABCB4, SLC30A10, FOXO1, BRIP1, PRKAR2B, CYC1, LYN, EGR1, EGR2, EIF2B3, TGFB1, CAV1, GGH, CDC6, NFKB1, NR4A2, COL1A1, NR4A1, CXCL12, NR4A3, CDK4, FBN1, BTG2, CDKN1B, ADM, HHEX, TIMP1, IL10, EDN1, ANXA1, ARG1, GLP2R, CAD, SIRT1, TGFBR3, CCNA2, CEACAM1, IL1B, TLR2, RETN, PTGS2, GNAI1, PAK1, PLN, FYN, CSK, SORT1, STAT1, SORBS1, TSHR, RPS6KB1, TEK]
GO:0030855;epithelial cell differentiation;4.0;0.5489353771682173;0.5244676885841086;6.961296045910167;21.066225782797595;4.034070439870987;7.050676185779127E-4;0.45630254989846264;[EHF, LGALS3, BASP1, AKT1, HOXA5, SOX4, MEN1, MED1, MEF2C, HNF1B, EREG, COL4A1, ADAM9, HOXB5, EPHA2, GATA3, PSAP, FZD1, ST14, JUN, TGFB1, JAG1, FZD2, VIL1, FA2H, BMP2, DAB2, CDK1, CD24, TGFB1I1, SLC7A11, TMEM100, HHEX, LBH, CD34, CTSB, DSP, ANXA1, PAX2, GREM1, ELF3, TST, RARA, FAM20C, YAP1, TAGLN, CEBPB, CSTA, HDAC2, PCNA, LEF1, RXRA, S1PR1, E2F7, E2F8, CDX2, AKR1C3, KLF4, USH2A, GRHL2]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[CX3CR1, HDAC2, EPB41L5, PDGFD, FYN, MEF2C, EDN1, POSTN, TGFB1, ARG1, CAV1, COL1A1, COL4A2, NOX4, XCL1, FBN1]
GO:0009913;epidermal cell differentiation;5.0;0.7436939687323844;0.6620879962271125;8.712233520617966;24.20171999872632;5.277263957350204;8.100097882234571E-4;0.560120536057681;[YAP1, CSTA, HDAC2, DSP, MED1, ST14, JAG1, ANXA1, AKR1C3, KLF4, USH2A, EREG, FA2H, ADAM9, EPHA2]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[CDKN1B, IHH, BRCA2, ETS1, CTGF, RUVBL2, CD38, PDGFRB, IL10, GHSR, POSTN, ANXA1, DUSP1, TACR3, CCNA2, IL1B, RARA, PCNA, ABCB4, PTGS2, SOCS2, CST3, RBBP8, TGFB1, NR2F2, POU4F1, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:0031145;anaphase-promoting complex-dependent catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;350.55619955642163;6.221725566191056;0.011732800519056534;0.7334203466557586;[BUB1B, AURKB, ANAPC10, AURKA, CDC20, CCNB1, CDC23, PTTG1, UBE2C, PLK1, UBE2S, CDK1, MAD2L1]
GO:0031146;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;350.55619955642163;6.063501560976162;0.011732800519056534;0.7253287636709003;[, CCNF, KIF14, SKP2]
GO:0016321;female meiosis chromosome segregation;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;64.47658740127405;8.390779266560578;0.0021579733551592936;0.7193458537639684;[PLK1, TTK, MLH1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, MED1, CDCA3, PRKDC, NEDD4L, ANAPC10, BARD1, HACE1, PLK1, SIRT1, RNF130, RNF43, CISH, FBXW2, CUL5, UBR1, SOCS2, FANCL, MARCH3, MARCH1, BCL2, ARRB1, ARRB2, BIRC5, DTL, BIRC2, BIRC3, UHRF1, NLRC4, ZNRF1, RNF24, CCNF, CDC20, HERC5, CDC23, TRIM25, SKP2, CDC34, NAIP, BRCA1, BMI1, RNF144A, RNF144B, PDZRN3, PCNA, PCNP, NEDD4, KLHL14, DTX3, UBE2C, UBE2S, UBE2T, UBE2M, TNFAIP3, UBE2Q2, HIST1H2BK, RNF6]
GO:0090307;mitotic spindle assembly;8.0;1.0;0.875;9.628524252492122;186.05212215721153;6.193554689224359;0.006226997092562797;0.6917386748366816;[KIF11, CDC20, TPX2, KIFC1, CHEK2, FLNA, BIRC5, NEK2, MYBL2, BIRC2, BIRC3]
GO:0035986;senescence-associated heterochromatin focus assembly;7.0;1.0;0.8509193652572005;9.628524252492122;78.57044775699477;8.67846133901236;0.0026296821776144383;0.7947362817240173;[CDKN2A, HMGA1]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, LST1, ICAM1, EPS8, TPM1, VRK1, CSF1R, EPB42, ARHGAP15, CORO1A, SPTA1, EPB41L3, MYH14, MYH10, FN1, CDC7, PARVB, PTK2, VIL1, FES, PLXNB2, ITGB2, ANXA1, RHOG, ARAP3, RHOH, ARAP1, RHOC, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD3, FGD4, CCL7, PDPN, CCL2, FYN, WASF3, SEMA4A, DLC1]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, F11R, ICAM1, ANPEP, CLEC5A, ITGB7, ITGB6, HAVCR1, CTSB, CR2, CR1, CXADR, EPHA2, GYPA, SELPLG, DPP4, NCAM1, SLAMF1, GPR15, CDK1]
GO:1904031;positive regulation of cyclin-dependent protein kinase activity;11.0;0.8653626801206646;0.8651102923899945;9.580896203502867;1273.8390836462854;6.063501560976162;0.04263424774889523;0.7425167041396421;[CDKN1A, CCNT2, CDKN1B, CCNH, CCNC, CKS1B, CCNB1, AKT1, CDC6, PSRC1, CKS2]
GO:0043200;response to amino acid;5.0;0.6441938053840475;0.612337914552944;8.412128928167629;56.712201515420396;5.104244793218563;0.0018981063470534028;0.5512723279577749;[CDKN1B, TNF, CTGF, ICAM1, ALAD, SESN3, PDGFRA, EDN1, CHUK, ARG1, MMP2, CYBB, ZEB1, COL4A1, COL6A1, RRAGD, PIK3C3, NAIP, CEBPB, DNMT1, PCNA, ABCB4, UBR1, PDGFD, PDGFC, FYN, LYN, COL1A1, COL3A1, COL1A2, RPS6KB1, COL5A2, BCL2L1]
GO:0044773;mitotic DNA damage checkpoint;9.0;0.8653626801206646;0.8289219652406215;9.50592193039979;276.28973210323346;5.926926025970411;0.009247168688879707;0.699343897778663;[BLM, CHEK2, TOPBP1, CLSPN, FANCI, TIPIN, DONSON, RPA2, MSH6, MSH2, CDK2, CDK1]
GO:0045740;positive regulation of DNA replication;8.0;0.7671156992804218;0.7585578496402109;9.427853557029971;747.3070825002359;6.166155715036245;0.025011695518573164;0.6903374900225189;[CDT1, JUN, PCNA, CDC7, EREG, CST3, DBF4, CDK2, CDK1, DNA2, E2F7, E2F8]
GO:0045862;positive regulation of proteolysis;8.0;0.6144040707577935;0.6822020353788967;8.732436227935485;336.2761553273835;3.9393431805145296;0.011254860289916062;0.5764581934497054;[ANTXR1, AKT1, SOX7, DAPK1, SFRP2, IFI27, AURKAIP1, TRIB1, C3, LYN, PLK2, PLK1, FN1, PTK2, CTSH, RIPK2, SIRT1, CBFA2T3, F3, RNF144A, RNF144B, IL1B, PERP, CASP8AP2, IL33, GSN, NLRP12, PSMC6, DLC1, PSMC2, FMR1, TNF, CLU, CTGF, PYCARD, F2R, PCOLCE, ADAM9, ADAM8, S100A9, S100A8, PSMD14, FBLN1, NLRP3, OSBPL7, CAV1, TNFRSF10B, DAB2, CCDC22, LRRK2, FASLG, ARRB1, CYR61, CR1, TNFRSF1B, AIM2, IFNG, ASPH, LCK, CEBPA, HDAC2, NLRC4, HSPD1, AURKA, FYN, SNCA, EGF, HSPE1, MAPK14, PML, P2RX1]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[CCNF, LGALS1, PSMD3, SKP2, ESCO2, MXRA8, SPARCL1, SDC2, C3, FN1, TF, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FAM20C, FSTL1, CST3, SPP1, PSMC6, PSMC2, NUCB1, DSCC1, TNC, MEN1, IGFBP5, CISH, APLP2, IGFBP3, FBXW2, PSMD14, CUL5, SOCS2, IGFBP7, NAE1, WFS1, IL6, COPS5, UBA3, CCDC22, UBE2M, FBN1, LAMC1, CYR61, VCAN, DTL, LAMB1]
GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity;11.0;0.7866048967936545;0.8257314007264895;9.474373572664863;340.6851601099881;5.181953777545879;0.011402425712143147;0.6974343094988531;[CDKN1A, CCNT2, CDKN1B, CCNH, CCNF, TNFAIP3, CCNC, CKS1B, HERC5, HHEX, AKT1, MEN1, MYOCD, CDC25C, CDC25A, CCNA2, PSRC1, CCNE2, CCNE1, CKS2, CEBPA, BLM, PKMYT1, CCNB2, CCNB1, SFN, CDKN2C, CDKN2A, PLK1, GTF2H1, CDC6, NR2F2, CDK6, CDK4, CDKN3]
GO:0006978;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;8.0;1.0;0.875;9.628524252492122;145.46952913610525;7.004484905440688;0.004868734226108882;0.7332096838060964;[CDKN1A, SP100, CHEK2, BRCA1, BRCA2, FOXM1]
GO:0050773;regulation of dendrite development;9.0;0.7586651285174919;0.775573189439035;9.510741216835738;86.24077544028233;4.857092701852345;0.002886401142327329;0.6446325718309276;[CYFIP1, LRRK2, FMR1, CDC20, YWHAH, MEF2C, DCC, SHANK3, NLGN1, HDAC2, SDC2, NEDD4L, RAB21, PLK2, NEDD4, ID1, CAMK1, EZH2]
GO:0051984;positive regulation of chromosome segregation;5.0;0.6634067003016617;0.6219443620117511;8.39638057119949;42.06625563378019;6.444869117505266;0.0014079197188904481;0.6198319182472036;[CDT1, FEN1, CDC6, CCNB1, ESPL1, RAD21, DLGAP5]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CDKN1A, FOXM1, PPP2R1A, CHEK2, NEK2, SKP2, TUBG1, MASTL, CDC25C, CKAP5, CDC25A, CIT, DNM2, CCNA2, MELK, PLCB1, PKMYT1, AURKA, CCNB2, CCNB1, PRKAR2B, CEP72, CEP76, PLK4, CEP152, PLK1, WEE1, CDK2, CDK1, CDK14]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[CDKN1A, BTG2, PCNA, CDKN1B, AURKA, CCNB1, CHEK2, E2F1, CASP2, SFN, E2F7, SOX4, E2F8, PLK2, CDC25C, PML, RBL2, TFDP1, CNOT3, CDK2, CDK1]
GO:0031938;regulation of chromatin silencing at telomere;11.0;0.8933024483968273;0.8790801765280758;9.551563211355994;304.6981139023377;9.083926447120524;0.010197971661811984;0.8969813732811862;[CDC45]
GO:2000615;regulation of histone H3-K9 acetylation;11.0;0.8933024483968273;0.8790801765280758;9.533214072687796;182.99191619144386;7.379178354882098;0.006124574752895117;0.8098004765652196;[CHEK1, GATA3, BRCA1]
GO:0000083;regulation of transcription involved in G1/S transition of mitotic cell cycle;10.0;0.8933024483968273;0.861892236059334;9.541512875502493;264.067998117236;6.444869117505266;0.008838118251214853;0.7448319182472036;[CDT1, PCNA, RRM2, GFI1, CDC6, TYMS, DHFR, POLA1, TFDP1, CDC45, CCNE1, E2F1, FBXO5, E2F7]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[CDKN1A, CDKN1B, MCM7, MCM8, GMNN, MCM10, SKP2, CDC25A, DBF4, CDC34, CCNE2, CCNE1, MCM3, MCM4, RHOU, MCM5, MCM6, BCAT1, MCM2, PRIM2, CUL5, PRIM1, IQGAP3, GSPT1, CDC45, RBBP8, RANBP2, RANBP1, CDT1, CDKN2C, CDKN2A, PLK2, RPA1, RPA2, CDC7, CDC6, INHBA, POLA1, POLA2, WEE1, CDK6, NASP, RPS6KB1, CDK4, POLE2, RPA3, CDK2, CDKN3]
GO:0071353;cellular response to interleukin-4;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;6.599019797332524;0.0027327542132076126;0.6605944919115335;[ARG1, LEF1, TCF7, GATA3, CORO1A, PML, ALAD, CDK4, IMPDH2, XCL1, MCM2]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[CDKN1A, FMR1, PTPRK, AQP1, RUVBL2, CHEK1, PBK, MME, SIRT1, CDC25A, PCNA, PTGS2, AURKB, POLD1, EIF2S1, MAPK13, MFAP4, NEDD4, ATR]
GO:0032465;regulation of cytokinesis;6.0;0.5930994877375815;0.6196700564589352;8.140447197062288;31.798591743249187;5.358233019883872;0.0010642702487719462;0.5971405984103235;[AHCTF1, KIF14, BRCA2, NUP62, PRKCE, TAS2R13, KIF23, CIT, PIK3C3, KIF20A, KIF20B, CXCR5, AURKB, AURKA, RACGAP1, ECT2, E2F7, E2F8, SVIL, PLK1, CDC6, PRC1, CALM3, BCL2L1]
GO:0071236;cellular response to antibiotic;4.0;0.6369964171292115;0.5684982085646058;7.703233390639544;41.40086873190647;5.085725745451326;0.0013856498180940687;0.5100842511328143;[SPI1, CDKN1B, TNFAIP3, ETS1, AQP1, IL18RAP, MYB, CYP1B1, MEF2C, ANXA1, ARG1, PRKCE, PRKCD, CYBB, PLA2G4A, SIRT1, PAX2, IL1B, TIMELESS, CFTR, HDAC2, PCNA, ABCB4, GNAI1, FOXO1, CST3, CCL7, PDGFD, ECT2, EGR1, KLF4, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:0051987;positive regulation of attachment of spindle microtubules to kinetochore;7.0;0.8653626801206646;0.7836007053175329;9.485423408851448;141.20478198009135;8.16763571524637;0.004725996976820352;0.7686126355688037;[CCNB1]
GO:0033316;meiotic spindle assembly checkpoint;12.0;0.9326813400603323;0.9144609826203107;9.607470843294289;1388.1064304510658;9.777073627680469;0.04645867301251565;0.9481203125901445;[TTK]
GO:0032467;positive regulation of cytokinesis;7.0;0.7043150770688792;0.7030769037916401;9.015419779605713;142.0565341908292;6.193554689224359;0.004754504356786525;0.6676580400938822;[SVIL, PRKCE, CXCR5, TAS2R13, KIF14, KIF23, CDC6, AURKB, CIT, RACGAP1, NUP62, ECT2, KIF20B]
GO:0033314;mitotic DNA replication checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;738.0966094602528;7.379178354882098;0.02470342927481251;0.8098004765652196;[CDC6, TOPBP1, NAE1, CLSPN]
GO:0060574;intestinal epithelial cell maturation;6.0;1.0;0.8231203125901445;9.628524252492122;41.35061092186203;8.390779266560578;0.0013839677344209735;0.7522251544931926;[CDKN1A, TYMS, HOXA5]
GO:0010571;positive regulation of nuclear cell cycle DNA replication;10.0;0.8436909121759173;0.837086467948879;9.54628615425515;1141.0186722643214;7.9853141584524145;0.038188868110550556;0.8236103492792612;[CDC7]
GO:0090400;stress-induced premature senescence;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;55.82928668984125;7.697632086000634;0.0018685559824130236;0.6838982747154925;[CDKN1A, MAPK14, SIRT1]
GO:0045995;regulation of embryonic development;5.0;0.5017827139744404;0.5411323688481404;6.887684228566921;27.37613670804801;4.981283082083729;9.162546586948941E-4;0.5449840603320351;[IL1RN, CELSR1, HNF4A, PHLDA2, PRKACB, IL10, HNF1B, DUSP6, SFRP2, PLCB1, LAMA2, LAMA4, LAMA3, GATA3, DLL1, GATA1, RACGAP1, FZD1, FZD2, CDX2, CDX1, IGF1, KLF4, SULF1, COL5A1, COL5A2, CDK1, FOXA2]
GO:0045875;negative regulation of sister chromatid cohesion;9.0;0.7369933605727446;0.7647373054666613;9.305750860229072;314.67461185837936;8.16763571524637;0.010531876070135456;0.8139338954918922;[ESPL1]
GO:0042246;tissue regeneration;4.0;0.7586651285174919;0.629332564258746;8.935377071932177;42.88961059103013;6.039404009397101;0.0014354766683382502;0.5588554019015759;[POSTN, GSN, GPX1, TXK, CCNB1, NINJ1]
GO:0046602;regulation of mitotic centrosome separation;9.0;0.8933024483968273;0.8428918493787028;9.503361109538115;111.3333211242262;7.212124270218933;0.003726226064543951;0.7650689957573628;[RANBP2, RANBP1, CHEK1, NEK2, KIF11]
GO:0045876;positive regulation of sister chromatid cohesion;9.0;0.7436939687323844;0.7680876095464813;9.292052015870908;259.00348872071737;7.474488534686424;0.008668613679475917;0.7784863164434164;[FEN1, RAD21]
GO:0071460;cellular response to cell-matrix adhesion;5.0;1.0;0.7902410118609202;9.628524252492122;47.10946963375147;9.083926447120524;0.001576711552871558;0.7547934328124444;[SKP2]
GO:0044791;positive regulation by host of viral release from host cell;9.0;1.0;0.896240625180289;9.628524252492122;253.86718028650722;8.16763571524637;0.008496706058560384;0.8139338954918922;[CAV2, SMC3]
GO:0001975;response to amphetamine;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;70.50276562849314;6.558197802812269;0.0023596641172160164;0.6585068532133508;[NR4A2, HDAC2, DRD4, ICAM1]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CSF3, CSF2, CD80, GFI1, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, ICAM1, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, IL10, GHSR, MEF2C, ARG1, PDE4D, CD180, PDCD1LG2, TNFRSF1B, IL1B, RARA, ADAM9, IRF8, TLR4, CX3CR1, CD274, CEBPB, CEBPE, SBNO2, KLRK1, STAP1, NLRP3, CCL2, CD14, ABCA1, CCL20, NR1H2, DEFA4, NR1H4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, CDK4, TNIP3, PF4]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[PPP2R1A, NEK2, TUBG1, CKAP5, PRKAR2B, CEP72, CEP76, PLK4, CEP152, PLK1, CDK1]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[, PSMD3, PRSS3, UQCRC1, PRKCQ, UQCRC2, CFB, CFD, ENPEP, CFI, NEDD4L, GATA3, ADAMTS12, CFP, ANAPC10, C2, C3, ELANE, BARD1, ST14, ACE, HACE1, PLK1, AZU1, TGFB1I1, IFIH1, MMP28, OLR1, RIPK2, ACTL6A, SIRT1, F3, MMP12, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, MMP19, IGLV3-19, FAM105A, ADAM28, USP1, USP9Y, F11, PSMC6, PSMC2, APEH, IGHG1, RUVBL1, RNF43, FBXW2, CDC25A, ADAM2, ADAM9, ADAM8, ADAM7, CUL5, AEBP1, UBR1, TMEM27, IGLV1-44, CLCA4, WFS1, DHCR24, NFKB1, COPS5, IGLV2-23, CDK1, ARRB1, ARRB2, SCPEP1, ADAMTS1, ADAMTS20, ASPH, ESPL1, MEP1A, PIK3C3, DTL, BIRC2, BIRC3, C1S, C1R, UHRF1, HM13, VPS4B, FGL2, IGHV3-48, ZNRF1, RNF24, GZMA, GZMB, PML, GZMH, GZMK, GZMM, EIF3F, CCNF, CDC20, CDC23, ANPEP, TRIM25, SKP2, ASRGL1, CDC34, IGKV4-1, CFTR, CTSZ, KIF14, CTSW, BRCA1, PCSK6, PCSK5, CTSS, CTSH, CTSG, CTSD, CTSB, MME, RNF144B, C1QB, C1QA, DERL3, CD5L, TMPRSS2, PCNP, IGKC, PERP, RANBP2, RANBP1, IL33, GCA, IGKV1-5, FAP, NEDD4, MAD2L1, C1QC, FCN1, IHH, BUB1B, PTTG1, PLAU, PCOLCE, ADAM12, PRTN3, PSMD14, PSEN2, HTRA1, ADRB2, TRHDE, DPP4, CCNB1, NLRP3, CLSPN, TGFB1, UBE2C, GGH, ISG15, NFKBIA, UBE2S, UBA3, IGKV3-20, TNFAIP3, CASP2, MMP1, DDX58, MMP2, MMP8, MMP9, CCNA2, LTF, RNF6, USP18, AURKB, AURKA, TBX21, NRIP3, TNIP3, CPVL, RBMX]
GO:0032212;positive regulation of telomere maintenance via telomerase;10.0;1.0;0.9152410118609203;9.628524252492122;1624.1830741800397;6.250713103064308;0.054359945822938814;0.734902770639515;[AURKB, NEK2, CCT8, CCT7, CCT5, CCT4, CCT3, CCT2, NEK7, CCT6A, PRKCQ, ATR]
GO:0071466;cellular response to xenobiotic stimulus;4.0;0.7436939687323844;0.6218469843661922;8.578702127993445;40.79473292833871;5.769740442447999;0.0013653629982354628;0.5450647945471605;[MCM7, FECH, ABCB4, AIF1, SLC8A1, FOXO1, AQP1, ICAM1, CHEK2, E2F1, EGR1, TGFB1, ARG1, CCNA2, RPS6KB1, APOBEC3A]
GO:0010569;regulation of double-strand break repair via homologous recombination;9.0;0.8436909121759173;0.8180860812682478;9.523163736834295;184.48234756552796;6.221725566191056;0.00617445814968456;0.7144199599751273;[POLQ, BLM, RPA2, RAD51AP1, RAD51, FIGNL1, CHEK1]
GO:0031000;response to caffeine;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;108.60320465904744;7.069023426578259;0.003634851523399718;0.6846304993685643;[HDAC2, CAD, SLC8A1]
GO:0070933;histone H4 deacetylation;10.0;0.8933024483968273;0.861892236059334;9.548481544818586;358.70493891627973;7.57984905034425;0.012005531492041683;0.8028748447945538;[HDAC2]
GO:0051754;meiotic sister chromatid cohesion, centromeric;7.0;1.0;0.8509193652572005;9.628524252492122;116.99733732322595;8.16763571524637;0.003915795589440837;0.7686126355688037;[PPP2R1A, BUB1B, BUB1]
GO:0070932;histone H3 deacetylation;10.0;0.8653626801206646;0.8479223519212526;9.510741216835738;358.70493891627973;6.781341354126479;0.012005531492041683;0.7620391240755716;[HDAC2, SIRT1]
GO:0007094;mitotic spindle assembly checkpoint;13.0;1.0;0.9625549647676366;9.628524252492122;1801.8011146821202;6.781341354126479;0.060304661792685066;0.8093530769822879;[PLK1, BUB1B, TTK, CENPF, TRIP13, BUB1, MAD1L1, MAD2L1]
GO:0007095;mitotic G2 DNA damage checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;857.7571147403349;6.7325511899570465;0.028708358699073767;0.7767319332797141;[MSH6, FANCI, BLM, DONSON, CDK1, TOPBP1, CLSPN]
GO:0007093;mitotic cell cycle checkpoint;7.0;0.7140352122741334;0.7079369713942671;9.0094850440859;132.2042645947957;5.142344639450834;0.0044247577598742595;0.6138991092621975;[TOP2A, ZWILCH, BUB1B, BRCA1, CHEK2, KNTC1, TOPBP1, TIPIN, MSH6, MSH2, MAD1L1, BLM, TTK, AURKB, NAE1, CLSPN, BUB1, FANCI, TGFB1, PLK2, PLK1, DONSON, RPA2, CDC6, ZWINT, WEE1, CENPF, CDK2, CDK1, TRIP13, MAD2L1, BCL2L1]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[PPP1R12A, PLK1, CETN3, CEP120, HEPACAM2, TUBE1, BRCA1, CKAP5, UXT, FES, NUP62, CDK1]
GO:0007099;centriole replication;6.0;1.0;0.8231203125901445;9.628524252492122;79.09414177220606;6.781341354126479;0.0026472097450095456;0.6699184248047958;[PLK4, CEP152, CDK2, CEP72]
GO:0007096;regulation of exit from mitosis;8.0;0.7763722522362496;0.7631861261181248;9.249034630787218;94.90422389775904;6.8867018697843045;0.0031763589656016605;0.7271862538851576;[ANLN, TGFB1, CDKN1B, CDC23, UBE2C, CDCA5, KNTC1, PHB2]
GO:0043068;positive regulation of programmed cell death;6.0;0.544374901031353;0.595307763105821;7.549082710812286;59.39447578849882;3.3868329606151195;0.001987879653083215;0.4963231076998412;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, PRKDC, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, FOSL1, NOX4, NOX1, SRPX, CDKN1A, ADM, CTLA4, TIMP3, ANXA1, DUSP1, RIPK2, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, CDKN2A, G0S2, POU4F1, TNF, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A9, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, CDK4, BCL2, BCL2L1, PLEKHF1, LRRK2, PIK3CD, FASLG, ARRB1, ARRB2, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, GZMA, GZMB, PML, P2RX1, MNDA, IFIT2, PPP2R1A, CHEK2, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, GADD45B, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, IL10, VAV1, IL1B, CXCR2, CTNNA1, APBB1, SORT1, AKR1C3, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, TGM2, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, NFKBID, UBE2M, TNFAIP8, CASP2, MYBL2, YWHAH, ARHGEF12, PLAUR, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
GO:0042771;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;8.0;1.0;0.875;9.628524252492122;164.97679920792456;6.409777797693995;0.005521625000009403;0.7027963346592216;[CDKN1A, BRCA2, SIRT1, PML, PYCARD, MSH2, CHEK2, BCL3]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[CSF1R, CD40, HDAC2, CSF2, IFNA2, GHR, CCL5, FYN, IL6R, LYN, IL15, LIF, IL18, OSM, IGF1, PARP9, GH1, IL6, IFNG, IL23A, KIT, HCLS1]
GO:0001302;replicative cell aging;4.0;1.0;0.75;9.628524252492122;26.138269705024182;8.16763571524637;8.748243641116619E-4;0.6676932703116032;[CHEK2]
GO:0000212;meiotic spindle organization;7.0;0.7671156992804218;0.7344772148974115;9.168991923113682;69.6769368299192;7.292166977892469;0.002332024370525413;0.7238411236270654;[ASPM, ESPL1, FBXO5, TUBG1, AURKA]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, RORA, PHB2, ETS1, SLC8A1, LOXL2, AQP1, ICAM1, EDNRA, PLAU, MYB, AKT1, POSTN, PRKCE, ACTN4, ATP1B1, CLDN3, ADAM8, ABCB4, PSEN2, TWIST1, DPP4, CCNB1, BRIP1, HMOX1, EGR1, TGFB2, TGFB1, VCAM1, CAV1, NR4A2, BMP2, CXCL12, BCL2, NOX4, CD24, SUV39H2, ALAS2, CDKN1B, SUV39H1, ADM, ALAD, CD38, MYOCD, ADSL, EDN1, KCND2, MMP2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, CCNA2, IL1B, LTA, BIRC2, TLR2, CXCR4, KCNA5, PTGS2, THBS1, ASCL2, CST3, PAK1, E2F1, PML, FABP1, TEK]
GO:0032967;positive regulation of collagen biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;105.22247330055487;6.558197802812269;0.003521701487291661;0.6585068532133508;[PDGFRB, HDAC2, TGFB1, MYB, F2R, IHH, ARRB2, ENG, CTGF]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[CDA, NRP1, SEMA5B, CDKN1A, CDKN1B, ARHGAP4, TCHP, PPP2R1A, HNF4A, TNR, SEMA6A, DCC, SIRT1, GREM1, PSRC1, SFRP2, NDUFS3, FBP1, RNF6, PAK1, FRZB, SPP1, APBB1, SEMA4A, TGFB2, TGFB1, CDKN2C, CDKN2A, SEMA4B, INHBA, PML, BCL6, BCL2, SIPA1]
GO:2000757;negative regulation of peptidyl-lysine acetylation;10.0;0.7866048967936545;0.8085434602577476;9.405380701177911;527.0473325231619;6.781341354126479;0.017639799907745887;0.7620391240755716;[HDAC2, SPI1, TWIST1, BRCA1, SIRT1, SNCA]
GO:0007091;metaphase/anaphase transition of mitotic cell cycle;10.0;1.0;0.9152410118609203;9.628524252492122;246.8513480975109;8.16763571524637;0.008261892469033718;0.8329342821725234;[CDC23, TACC3, BUB1B]
GO:0043517;positive regulation of DNA damage response, signal transduction by p53 class mediator;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;407.3955344582497;7.138016298065211;0.013635161906140381;0.7612791106150483;[ATR]
GO:0040001;establishment of mitotic spindle localization;7.0;0.8933024483968273;0.7975705894556142;9.577230958104572;138.61878563688504;6.481236761676141;0.0046394460064588475;0.6823701146576509;[GPSM2, CENPA, NDC80, ESPL1, NUSAP1]
GO:0014075;response to amine;5.0;0.7980440201809971;0.6892630219514189;9.223059144383958;29.79647000066773;6.139487467954083;9.972610358403309E-4;0.6042146864874571;[HDAC2, ARG1, CAD, NME1, ICAM1, NR4A2, CDK1, DRD4]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[CDKN1A, BCL2A1, PRKDC, BRCA1, BRCA2, TNF, PYCARD, CHEK2, E2F1, HMOX1, CASP2, SFN, MLH1, TNFRSF1B, SIRT1, PML, MSH6, MSH2, BCL3, BCL2, EPHA2, BCL2L1]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[CALML4, UXT, CDC20, CHEK2, STMN1, FBXO5, MAP1B, KIF20A, LLGL2, PRKCZ, FIGNL1, CEP72, PLK2, PLK1, PTK2, TPX2, CETN3, KIF11, NUF2, TUBG1, KIFC1, KIF2C, CENPA, FLNA, RANBP2, RANBP1, CENPW, TUBE1, CENPE, TACC3, SPC25, CEP120, NUSAP1, NEK2, GAS2L3, MAP7D1, MAP7D2, CCNB1, STIL, NEK7, NDC80, KIF18A, KIF18B, FES, KIF4A, CDK1, GPSM2, MYBL2, NAV1, CKAP5, ASPM, PSRC1, ESPL1, BIRC5, BIRC2, BIRC3, VPS4B, TTK, AURKB, AURKA, POC1A, SPAG5, WEE1, PRC1, RAN]
GO:0006334;nucleosome assembly;7.0;0.8653626801206646;0.7836007053175329;9.474373572664863;104.51542930890014;4.99795013456894;0.0034980373611892576;0.6065147675675062;[HMGB2, HJURP, CHAF1B, CHAF1A, RUVBL1, OIP5, BRD2, H2AFX, PADI4, MCM2, ASF1B, HIST1H2BK, CENPA, H1FX, CENPW, NASP, CENPH, CENPI, CENPK, CENPL, CENPM, CENPN, CENPO]
GO:1903926;cellular response to bisphenol A;6.0;1.0;0.8231203125901445;9.628524252492122;371.8118467259178;9.777073627680469;0.012444207900979068;0.8231203125901445;[CHEK2]
GO:0001556;oocyte maturation;4.0;1.0;0.75;9.628524252492122;79.08984218955116;6.8867018697843045;0.0026470658418474595;0.6021862538851576;[CCNB1, FBXO5, TRIP13, BRCA2, EREG]
GO:0045143;homologous chromosome segregation;5.0;1.0;0.7902410118609202;9.628524252492122;44.56456858672447;7.697632086000634;0.00149153600508981;0.6838982747154925;[ESPL1, PTTG1, PLK1, PTTG3P]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, CD40, TFRC, TNFSF13B, CD38, NCKAP1L, CD74, MEF2C, FCRL3, MIF, MSH6, BST1, PTPRC, BCL6, BCL2, CARD11, CD320]
GO:0010942;positive regulation of cell death;5.0;0.5391707831400974;0.559826403430969;7.325939159498076;41.77857356132841;3.304727333179569;0.0013982912588225433;0.45924492136526085;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, PRKDC, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, FOSL1, NOX4, NOX1, SRPX, CDKN1A, CDKN1B, ADM, CTLA4, TIMP3, ANXA1, DUSP1, RIPK2, PAWR, FOS, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, CDKN2A, G0S2, POU4F1, HP, TNF, CLU, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A9, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, CDK4, BCL2, BCL2L1, ITGAM, PLEKHF1, LRRK2, ITGB2, PIK3CD, FASLG, ARRB1, ARRB2, CYR61, ITGA4, TFDP1, LCK, LRP1, NLRC4, CCL5, E2F1, CCL2, FYN, GZMA, GZMB, PML, P2RX1, MNDA, FCGR2B, IFIT2, PPP2R1A, CHEK2, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, EGR1, GADD45B, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, CD36, IL10, VAV1, IL1B, TLR6, TLR4, CXCR2, CTNNA1, APBB1, SORT1, AKR1C3, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, TGM2, PDGFRB, KMO, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, NFKBID, UBE2M, TNFAIP8, CASP2, MYBL2, YWHAH, ARHGEF12, PLAUR, AXIN2, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
GO:0048096;chromatin-mediated maintenance of transcription;11.0;1.0;0.9324289523296623;9.628524252492122;1311.6223032101445;7.57984905034425;0.043898818105007634;0.8200627852632958;[CHEK1, PADI2]
GO:0070317;negative regulation of G0 to G1 transition;7.0;1.0;0.8509193652572005;9.628524252492122;83.03241800612349;6.139487467954083;0.002779020306340262;0.6648930398837374;[EHMT2, BRCA1, BMI1, UXT, CHEK1, RBBP8, E2F1, RRM2, CDC7, RAD51, TFDP1, EZH2]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[IL1RN, AQP9, IFIT1, AQP1, ICAM1, LGALS1, CHEK2, AKT1, CYP1B1, MED1, MEF2C, KCNQ1, CFTR, ABCB4, ABCA1, EGR1, JUP, COL1A1, ID1, NOX4, EZH2, GABRB1, CDKN1B, BRCA1, IFIH1, IL10, EDN1, ANXA1, ARG1, IL15, IL18, IL1B, PTAFR, PTGS2, AIF1, GNAI1, CTNNA1, SPP1, P2RY13, STAT1, AKR1C3, POU4F1, TNC, RORA, TNF, SLC8A1, CDH1, RUVBL2, IGFBP5, ADCYAP1, BLM, FECH, FOXO1, CCNB1, OSBPL7, TGFB1, CAV1, INHBA, NFKB1, NFKBIA, BMP2, KIF18A, NR4A3, CDK4, ALPL, SLC26A3, LRRK2, PDE4B, DDX58, PDE4D, DNM2, CCNA2, COLEC12, CEBPA, CEBPB, HDAC2, NOD2, P2RY6, CCL5, CCL2, SNCA, KLF4, RAD51, KLF5, RPS6KB1]
GO:0033129;positive regulation of histone phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1473.5624568792941;7.697632086000634;0.04931880931163779;0.8088982747154926;[CCNB1, IL1B, FMR1]
GO:0010389;regulation of G2/M transition of mitotic cell cycle;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;58.92720908338202;4.74012102526684;0.001972240656975688;0.6174100096703167;[PPP2R1A, NEK2, CDC25C, CDC25A, MSH6, BLM, HMMR, CCNB1, PRKAR2B, RAD21, CEP72, NAE1, CLSPN, CEP76, FANCI, PLK4, PLK1, CDC7, CDC6, TPX2, CDK6, CDK4, PKIA, CDK2, CDK1, KIF14, BRCA1, TOPBP1, TUBG1, CKAP5, RAD51C, DTL, SMARCD3, VPS4B, AURKB, AURKA, CEP152, DONSON, CENPF]
GO:0040014;regulation of multicellular organism growth;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;36.77819272999274;5.557565922504363;0.0012309330124483187;0.5744551915910391;[PRL, ADRB2, GHR, SOCS2, PLS1, GHSR, NPY1R, IGF1, VIL1, GH1, CDK4, BCL2]
GO:0090399;replicative senescence;4.0;1.0;0.75;9.628524252492122;26.138269705024182;7.212124270218933;8.748243641116619E-4;0.6188283705770736;[CDKN1A, MME, CDKN2A, CHEK2, CHEK1, SERPINE1, ATR]
GO:0007077;mitotic nuclear envelope disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;74.08347249058063;7.292166977892469;0.002479507153463127;0.6960420709600095;[CCNB2, CCNB1, PRKCB, PLK1, CDK1, VRK1]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[IFITM1, SPARC, LST1, SPINT2, ADARB1, PHB2, IFIT3, CYP1B1, EPHB1, SOX7, SOX4, MED1, MEF2C, HLA-G, EREG, SFRP4, SFRP2, SPINT1, BTK, TRIB1, GATA3, GATA1, BRIP1, INPP5D, HMOX1, SFN, S100A11, LYN, JUN, BCL11B, FZD5, LIF, EIF2AK2, CDC6, NR2F2, FOSL1, NOX4, SNAI2, SRPX, CDKN1A, BTG2, CDKN1B, TNFRSF13B, TGFB1I1, ADM, PRL, PTPRK, BRCA2, LRRC32, HNF4A, TIMP2, CTLA4, CD33, HAVCR2, IL10, DUSP1, ARG1, IL15, NOG, PAWR, PDCD1LG2, CBFA2T3, NME1, IL1A, CEACAM1, ZEB1, IL1B, RARA, TLR2, PTGS2, ASCL2, AIF1, PAK1, GPNMB, FRZB, PDPN, CTNNA1, CCL23, CDKN2C, STAT1, CDKN2A, OSM, LILRB1, LILRB2, PODN, SULF1, FAP, FABP7, DLC1, PKN1, CDKN3, CD86, CD80, SIRPG, IHH, TNF, ETS1, CDH5, DACH1, MEN1, IGFBP5, CD300A, IGFBP3, F2R, TPM1, TSC2, ADCYAP1, HGS, MAD1L1, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, CDK6, BCL6, OGN, BCL2, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, KLF13, AXIN2, TGFBR3, GREM1, TFDP1, IFNG, ASPH, LTA, XCL1, PDE5A, CEBPA, CEBPB, NLRC3, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, SOD2, PML, MEIS1, DNAJA3, IL2RA, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MED1, MEF2C, PRKCH, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PRKDC, PDGFA, IQGAP3, GATA1, PRKCZ, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, MCTS1, JUN, FN1, CDC7, CDC6, FOSL2, FOSL1, NOX1, CDKN1A, CDKN1B, ADM, HOXC10, TIMP1, JAK3, HLA-DPA1, HAVCR2, ANXA1, ARG1, RIPK2, FCRL3, EMP2, SIRT1, F3, PAX2, MMP12, RARA, HCLS1, HBEGF, PTAFR, KCNA5, PTGS2, NRAS, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, STAT1, LRG1, HLA-DPB1, CSF3, CHRM1, CSF2, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, PPP1R16B, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, DNMT1, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, CDK6, BCL6, CDK4, CDK2, CDK1, BCL2, HPSE, BCL2L1, ITGB3, FASLG, ARRB1, FOXM1, CYR61, TNFSF13B, LBH, ITGA4, ASPM, XCL1, BIRC5, CX3CR1, HDAC2, SMARCD3, TTK, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, PML, KLF5, PRC1, DNAJA3, IL2RA, PTPN6, CCNF, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, TIPIN, FLT3LG, MIF, RUNX2, EREG, HLA-E, BTC, SFRP2, IL23A, KIF20B, EBI3, TGFA, TWIST1, CD1D, PKHD1, SLAMF1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, IGF1, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, KIF14, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CD38, CCR3, CCR2, IL10, EDN1, SYK, IL15, NOG, RHOG, IL18, PDCD1LG2, AVPR1A, GAB2, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, AIF1, GNAI2, CST3, PURA, PAK1, CXCR2, CD74, CDX2, OSM, AKR1C3, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, ETS1, IL6R, TGM2, PDGFRB, GHSR, PDGFRA, MATK, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, HTRA1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, IL7R, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, TBC1D8, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, LEF1, DLL1, THBS1, HLX, S1PR1, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, RPS6KB1, TEK]
GO:0090398;cellular senescence;4.0;0.8653626801206646;0.6826813400603323;9.446202695698167;55.136139509281044;6.343086423195323;0.0018453569700716361;0.5743857346658935;[CDKN1A, CDKN2A, PRKCD, H2AFX, HMGA1, MAPK14, SIRT1, PML]
GO:0051271;negative regulation of cellular component movement;5.0;0.5470854108181258;0.5637837172699831;7.364160372318274;52.38761662992485;4.128099389519264;0.001753366382809582;0.5013522066171892;[SEMA5B, IL1RN, IFITM1, SERPINE1, SPINT2, ADARB1, CXCL13, DACH1, ARHGDIB, DPYSL3, CYP1B1, HOXA7, MEF2C, SEMA6A, IGFBP5, CD300A, ACTN1, IGFBP3, TPM1, ACTN4, MIF, SFRP2, PADI2, TRIB1, NBL1, VCL, KCNE3, TACSTD2, FBLN1, GATA3, THY1, PKHD1, KLRK1, RRAS, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, CXCL12, BCL2, GPR18, NRP1, PTPRR, MCTP1, CDKN1B, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, NOG, ARAP3, DCN, TGFBR3, GREM1, TMEFF2, PLCB1, ENG, CX3CR1, SP100, LRP1, THBS1, AIF1, SPOCK3, CTNNA1, CCL2, IL33, SEMA4A, CCL21, SEMA4B, TIE1, PODN, KLF4, SULF1, COL3A1, DLC1, CD9]
GO:1905448;positive regulation of mitochondrial ATP synthesis coupled electron transport;12.0;0.9326813400603323;0.9144609826203107;9.600353375525426;1375.5648477489242;8.390779266560578;0.04603891752616661;0.8772251544931927;[CCNB1, CDK1]
GO:1904117;cellular response to vasopressin;8.0;1.0;0.875;9.628524252492122;462.69925393661634;8.67846133901236;0.015486127626965131;0.8188169164668168;[CDC6]
GO:0001890;placenta development;4.0;1.0;0.75;9.628524252492122;49.86610466882393;6.193554689224359;0.0016689736466849693;0.5667386748366816;[CDKN1B, ABCB4, CCNF, HTRA1, MAPK14, ASCL2, PTK2, DCN, PHLDA2, E2F7, BIRC2, E2F8]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, PRKDC, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, FOSL2, FOSL1, HOXC10, DLGAP5, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, ZEB1, TAL1, RARA, HCLS1, ENG, NR1I2, EPCAM, STAT4, STAT1, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, SBNO2, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, FOXM1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, UHRF1, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, CCNC, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, IGF1, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, NOG, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RELB, RXRA, APBB1, IL33, CDX1, OSM, LILRB1, GRHL2, F2RL1, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL2, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, RBL1, ELF3, IRF7, IRF8, TAF9, LEF1, DLL1, S1PR1, LUM, MAPK14, MEIS2, MEIS1, TNIP3, RBMX]
GO:0006302;double-strand break repair;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;183.0506323445446;4.689477292448085;0.006126539929698291;0.6148200868187911;[DCLRE1A, FEN1, MCM8, BRCA1, BRCA2, CHEK2, H2AFX, ESCO2, PARP9, RAD51C, MSH2, BLM, PSMD14, PRKDC, CDCA5, RAD54B, RAD51AP1, BRIP1, CDC45, RAD21, RBBP8, RAD54L, APBB1, BARD1, GINS2, POLQ, GINS4, RPA1, RPA2, CDC7, MND1, MLH1, POLA1, RAD50, RAD51, RPA3, TRIP13]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[SLC46A2, PRKDC, GATA3, CCNB2, HOXA3, BCL11B, MAFB, BCL2, MAD1L1]
GO:1902977;mitotic DNA replication preinitiation complex assembly;8.0;1.0;0.875;9.628524252492122;93.82476133550486;9.777073627680469;0.003140230325096247;0.875;[CDC45]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, TGM2, PDGFRB, IL10, EDN1, IGFBP5, MMP2, IL18, MMP9, EREG, HBEGF, DNMT1, CALCRL, PTAFR, PTGS2, THBS1, AIF1, GNAI2, PAK1, CCL5, PDGFD, S1PR1, HMOX1, ELANE, JUN, STAT1, IGF1, IL6, NR4A3, RPS6KB1, NOX1]
GO:0071314;cellular response to cocaine;7.0;1.0;0.8509193652572005;9.628524252492122;537.09778937307;8.67846133901236;0.017976179653688387;0.7947362817240173;[CCNA2]
GO:2000774;positive regulation of cellular senescence;7.0;1.0;0.8509193652572005;9.628524252492122;164.05173707047635;7.474488534686424;0.005490664002770884;0.7331650565203278;[CDKN2A, HMGA1, PAWR, SIRT1]
GO:2000775;histone H3-S10 phosphorylation involved in chromosome condensation;12.0;1.0;0.9481203125901445;9.628524252492122;711.4828594708514;9.777073627680469;0.023812691013487215;0.9481203125901445;[CCNB1]
GO:0031297;replication fork processing;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;150.6515651586252;6.375876246018314;0.005042172308252987;0.701062607729944;[SMARCAL1, BLM, PCNA, BRCA2, RAD51, DNA2]
GO:0070345;negative regulation of fat cell proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.87354995152188;8.16763571524637;0.0021377902344145586;0.7408135829017477;[TFDP1, E2F1]
GO:0030521;androgen receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;54.01143535742291;5.948432231191374;0.0018077141342769656;0.6792031009335148;[TGFB1I1, FHL2, BRCA1, MED1, CCNE1, RAN]
GO:2000773;negative regulation of cellular senescence;7.0;1.0;0.8509193652572005;9.628524252492122;164.4250159730019;7.004484905440688;0.005503157311709213;0.7091290490632969;[CDK6, RBL1, BCL6, PRKDC, PLK2, TWIST1, SLC30A10, SIRT1]
GO:0016358;dendrite development;6.0;0.8259837884571596;0.7361122068187242;9.260799472366804;32.63417926892749;6.343086423195323;0.0010922366112764486;0.647506047256038;[NRP1, HDAC2, LST1, CD3E, MAP1B]
GO:0014038;regulation of Schwann cell differentiation;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;65.83981520803086;8.67846133901236;0.0022035993630260702;0.8400575416471059;[CDK1]
GO:0060770;negative regulation of epithelial cell proliferation involved in prostate gland development;7.0;1.0;0.8509193652572005;9.628524252492122;209.0820823569653;7.9853141584524145;0.006997789134829996;0.7592887026755414;[CDKN1B]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[CDC20, RUVBL1, PSMD3, SKP2, CDC25A, CFTR, PSMD14, ADRB2, GATA3, NLRP3, CLSPN, BARD1, NFKBIA, COPS5, CDK1, TNFAIP3, BRCA1, ARRB2, IFIH1, DDX58, ACTL6A, PSMA5, CCNA2, PSMA6, PSMA3, PSMA4, PSMA2, BIRC2, BIRC3, USP18, FAM105A, USP1, IL33, USP9Y, PSMC6, TNIP3, PSMC2, EIF3F]
GO:0045839;negative regulation of mitotic nuclear division;8.0;0.6997970393407541;0.724898519670377;9.076455670192082;276.53900459362586;6.166155715036245;0.009255511614802463;0.6903374900225189;[PLK1, BUB1B, TTK, CENPF, PTTG1, RAD21, CHEK1, TRIP13, AURKAIP1, BUB1, MAD1L1, PTTG3P, MAD2L1]
GO:1902065;response to L-glutamate;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;96.09026658308662;7.474488534686424;0.0032160547469104574;0.7053660038532718;[PCNA, ABCB4, FYN]
GO:0007088;regulation of mitotic nuclear division;7.0;0.5860072649471136;0.6439229977307573;8.169909229792605;54.97351338155213;4.573066940603674;0.0018399140199305624;0.5847862212690335;[CCNF, BUB1B, SMC3, MKI67, PHB2, CDC23, PTTG1, CHEK1, NUSAP1, KNTC1, NEK2, FBXO5, PDGFRB, CDC25C, EREG, BTC, CCNE2, CCNE1, AURKAIP1, KIF20B, MAD1L1, CDCA5, TGFA, PKMYT1, CCNB2, CCNB1, RAD21, CDT1, TGFB1, CAV2, UBE2C, PLK1, CDC6, IGF1, NDC80, ANLN, STAG2, CD28, PTTG3P, CDKN1B, KIF11, NUP62, DLGAP5, EDN1, DUSP1, SMC1A, CCNA2, IL1A, ESPL1, IL1B, VPS4B, TTK, AURKA, BUB1, SH2B1, RANBP2, RANBP1, EGF, CENPE, CENPF, TACC3, TRIP13, MAD2L1]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[CCNF, HERC5, CDC23, SKP2, FBXW2, CDC34, NEDD4L, ANAPC10, BARD1, HACE1, UBE2C, MARCH1, UBE2S, UBE2T, BCL2, TNFAIP3, BRCA1, UBE2Q2, RNF144A, RNF144B, DTL, BIRC2, RNF6, ZNRF1, RNF24, NEDD4]
GO:0090166;Golgi disassembly;5.0;1.0;0.7902410118609202;9.628524252492122;58.9131161342151;7.9853141584524145;0.001971768978649902;0.6986103492792611;[CDK1, VRK1]
GO:0040020;regulation of meiotic nuclear division;7.0;0.609056648853049;0.655447689683725;8.529911963824013;66.11398289201945;6.280566066213989;0.002212775508674272;0.6721078059595746;[LIF, TTK, BRCA2, CDC20, MSH2, FBXO5, TRIP13, PLCB1]
GO:0007089;traversing start control point of mitotic cell cycle;10.0;1.0;0.9152410118609203;9.628524252492122;354.407431007331;8.390779266560578;0.01186169776983519;0.8443458537639685;[CDC6]
GO:0035094;response to nicotine;4.0;0.9326813400603323;0.7163406700301662;9.446202695698167;26.17342148764107;5.926926025970411;8.760008626412986E-4;0.5531032725983739;[CHRNB4, EDN1, HDAC2, VCAM1, SLC7A11, TNF, NFKB1, CNR1, BCL2, HMOX1]
GO:0042325;regulation of phosphorylation;7.0;0.468531447706225;0.585185089110313;6.879652056869657;31.28210038194581;2.461190123170684;0.001046983747721169;0.4767847426131948;[, PID1, AKT1, PRKACB, PRKAR1B, ATF3, FPR1, PDGFA, FPR2, THY1, SLC30A10, IQGAP3, GATA1, C3, PRKAR2B, PDGFD, PDGFC, SFN, LYN, JUN, FN1, EIF2AK2, AZU1, NR2F2, PKIA, NOX4, PKIG, NOX1, EZH2, LRRC4, DUSP2, GPR37, DUSP3, DUSP1, RIPK2, BGN, EMP2, SIRT1, DUSP6, CKS2, LRRC19, PTGS2, NTF3, DMD, CENPE, PKN1, CDKN3, CCNT2, NCF1, CTGF, MAP3K8, IFNA14, CISH, IFNA16, CDC25C, CDC25A, ADCYAP1, IFNA10, BLM, PFKFB4, TNFRSF11A, PKMYT1, FOXO1, SOCS2, IFNA21, TNFRSF10B, CXCL10, PTPRC, LRRK2, ITGB3, ITGB2, ARRB1, ARRB2, FOXM1, HHEX, LCP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, TIE1, PTPN6, FCGR2B, CCNH, CCNF, CCNC, ICAM1, HERC5, TCL1A, TNFSF11, EPHB2, EPHB1, PAQR3, MIF, EREG, SFRP2, TRIB1, EPHA3, EPHA2, TGFA, PIK3R3, PIK3R5, PKHD1, RRAS, SLAMF1, CCR1, EGR1, IGF1, PTK2, BST1, ID1, CD27, CALM3, CD24, NRP1, PTPRR, CD40, KIF14, CD3E, RAC2, CCR7, CD36, SYK, IL15, IL18, BANK1, IL1B, KIT, GNAI2, PAK1, CD74, OSM, NLRP12, FOXA2, CD80, IL6R, PDGFRB, PDGFRA, CCNE2, CCNE1, CALCA, RASGRP1, CCNB2, CCNB1, ECT2, CAV2, CAV1, INHBA, GH1, IL6, BMP2, GNAQ, TNFAIP3, GHR, GRM5, NUP62, MYOCD, IRAK3, MMP9, CCNA2, GREM1, PSRC1, NDUFS4, CHI3L1, ZMYND11, FBP1, EGF, MAPK14, CD4, TEK, ADARB1, PHB2, PROK2, ROPN1L, PRKCE, PRKCD, PRKDC, PRKCZ, SAMSN1, FLRT2, S100A12, NCKAP1L, ELANE, BARD1, FZD1, ACE, FZD5, PLK1, FZD8, CDC6, CDKN1A, CDKN1B, TIMP2, PBK, TIMP3, HAVCR2, FCRL3, HCLS1, PLCB1, HBEGF, ENG, CCL13, FAM129A, GPNMB, CCL19, CCL18, CCL23, CDKN2C, CCL21, CCL20, CDKN2A, CARD9, GTF2H1, ELP4, CSF3, CSF2, FMR1, TNF, CLU, PYCARD, MEN1, MAP2K2, IGFBP3, F2R, ADAM9, ADAM8, CSF1R, PSAP, DRD4, MAP2K6, DAB2, COPS5, CDK6, CDK4, CDK1, BCL2, PLXNB2, CSPG4, LAT, MCM7, TREM2, PTPN22, CYR61, DUSP10, EMILIN1, XCL2, XCL1, CEBPA, HDAC2, TTK, NOD2, CSK, KLF4, PML, RAD50, PPIL4, IL1RN, EDNRB, PPP2R1A, CHEK2, ACSL1, SLC11A1, FLT3LG, COX7A2L, IL23A, TWIST1, GADD45B, LIF, MARCO, TPX2, IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, MAP4K1, EDN1, STRADB, NOG, RHOH, GP1BA, PARP9, CBFA2T3, CEACAM1, MDFIC, TLR8, TLR7, TLR6, TLR4, CXCR4, AIF1, PODN, CD40LG, F2RL1, CAMK1, CD300A, TSC2, HGS, C5AR1, FBLN1, ADRB2, HRH4, STAP1, CLSPN, FAM83D, TGFB2, TGFB1, CKS1B, LRRTM4, PDE4D, PLAUR, AXIN2, DCN, FGR, RBL2, RBL1, IFNG, PDE5A, LTF, THBS1, SNCA, LTBR]
GO:1902746;regulation of lens fiber cell differentiation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;57.42001436262624;8.67846133901236;0.0019217962060591768;0.7669372290569613;[CDKN1B]
GO:1903827;regulation of cellular protein localization;5.0;0.4816167172285496;0.5310493704751951;6.85593553025234;25.722958397114;3.605373030269554;8.609242683918189E-4;0.47461995629589737;[, PID1, AKT1, EPHB2, MED1, PRKCH, PRKCE, PRKCD, PDZK1, IFI27, KIF20B, EPHA3, EPHA2, CDCA5, NEDD4L, TP53BP2, CEP72, SFN, BARD1, CDT1, JUP, FZD5, PLK1, LIF, IGF1, CCT6A, PKIA, PKIG, CDKN1A, XPO1, RAC2, CD36, CCT3, CCT2, FCER1G, RHOG, PARP9, SIRT1, MDFIC, IL1B, HCLS1, RHOU, SP100, DERL3, PTGS2, GNAI1, PAK1, CCT8, CCT7, CCT5, CCT4, GSN, SORBS1, LILRB4, NUCB1, GOPC, CAMK1, CHRM1, TNF, CDH1, AP2M1, PLS1, CCNE2, CCNE1, ECT2, TGFB1, NDC80, VIL1, DAB2, CDK1, BCL2, BCL2L1, GPSM2, ITGAM, LRRK2, ITGB2, TREM2, NUP62, YWHAH, TFDP1, IFNG, NUP54, LCP1, LRP1, ABLIM3, E2F1, FYN, CSK, EGF, GZMB, MAPK14, CD247]
GO:0010923;negative regulation of phosphatase activity;9.0;0.7866048967936545;0.7895430735771163;9.362821086759116;265.75489588375854;5.142344639450834;0.008894577201350937;0.659220369185286;[PLEKHF2, PLEKHF1, TNF, PPP1R12A, MASTL, PPP1R15A, PKMYT1, GNAI2, NCKAP1L, TGFB2, FKBP1B]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[LYN, ABCA1, YAP1, HDAC2, TNC, KLF4, PHB2, PAX2, AQP1, COL1A1, MYB, RARA, HOXA2, EPHA3]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, IL1RN, CSF3, SPARC, CSF2, CD80, GFI1, SERPINE1, CXCL13, MPO, LOXL1, ICAM1, PYCARD, EDNRB, JUNB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, TRIB1, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, SBNO2, KLRK1, PLCG2, STAP1, NLRP3, S100A14, CD14, ELANE, ABCA1, JUN, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, NFKB2, SELP, CXCL10, CXCL11, IL6, CDK4, ALPL, CD27, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, ADM, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, IL10, PTGIR, EDN1, CHUK, ARG1, PDE4D, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, RARA, IRF8, TLR4, CX3CR1, CEBPB, HDAC2, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, SNCA, GCH1, CCL20, NR1H2, IL10RA, NR1H4, LILRB1, LILRB2, MAPK14, CD6, RPS6KB1, TNIP3, LTBR, PF4]
GO:0010800;positive regulation of peptidyl-threonine phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;778.6672313762616;6.375876246018314;0.026061291479152104;0.7413036195908642;[TGFB1, EGF, RIPK2, PLK1, AZU1, CHI3L1, CALM3]
GO:0035407;histone H3-T11 phosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;710.1813063381824;9.083926447120524;0.02376912920145855;0.8969813732811862;[CHEK1, PKN1]
GO:0010243;response to organonitrogen compound;4.0;0.45240132074476547;0.47620066037238273;6.234015858980763;25.42702214820504;3.12938525411714;8.510195484661687E-4;0.4100369074268474;[CYFIP1, AKT1, PRKACB, JUNB, MEF2C, PRKCE, PRKCD, ADCY9, PRKAR1B, UQCRC1, PRKDC, ABCB4, FPR2, SLC30A10, PRKAR2B, PDGFD, PDGFC, LYN, ABCA1, JUN, JAG1, JUP, CDC6, COL1A1, FOSL1, DHFR, COL1A2, NOX4, EZH2, CDKN1A, GABRB1, BTG2, CDKN1B, ADM, TIMP1, ANXA1, DUSP1, ARG1, RIPK2, TACR3, FOS, SIRT1, ZEB1, MMP19, PTAFR, PTGS2, GSN, STAT1, CARD9, NR1H4, COL3A1, PSMC6, PSMC2, FOSB, TNF, SLC8A1, CTGF, SESN3, CDH1, MEN1, LHCGR, IGFBP5, RAB31, BLM, DNMT1, UBR1, FOXO1, DRD4, EIF2B3, WFS1, NFKB1, CXCL12, CDK4, CDK1, SLC26A3, MYD88, BCL2L1, LRRK2, ITGB2, TREM2, PTPN22, ALAD, THBD, HHEX, TRPC3, CHUK, PIK3C3, BIRC2, CEBPB, HDAC2, LRP1, NOD2, PLN, FYN, CSK, KLF4, KLF1, P2RX5, RAD51, KLF5, P2RX1, FCGR2B, IL1RN, SPARC, AQP9, AQP1, ICAM1, EDNRB, TRIM25, EREG, POR, KCNQ1, RRAGD, NAIP, CFTR, MGST1, BRIP1, EGR1, EGR2, IGF1, ID1, SDC1, CD40, BRCA1, CD36, IL10, EDN1, FCER1G, SYK, AVPR1A, NME1, CEACAM1, IL1B, TLR6, TLR4, TLR2, PCNA, DERL3, TYMS, AIF1, GNAI1, PAK1, CTNNA1, SORT1, SORBS1, GHSR, PDGFRA, CYBB, COL4A1, TIMELESS, C5AR1, ADRB2, NLRP3, CYC1, TGFB1, CAV1, GGH, NR4A2, NFKBIA, NR4A1, IL6, NR4A3, SELL, COL5A2, FBN1, TNFAIP3, GRM5, KYNU, PDE4B, MMP2, PDE4D, GLP2R, CAD, IRAK3, DNM2, TGFBR3, CCNA2, NDUFS4, COL6A1, RETN, CNR1, SNCA, MAPK14, TSHR, MAPK13, RPS6KB1, CD9, TEK]
GO:0007080;mitotic metaphase plate congression;7.0;1.0;0.8509193652572005;9.628524252492122;61.63195576956532;6.193554689224359;0.002062766094448262;0.6676580400938822;[SEH1L, CDCA5, VPS4B, KIF14, CDCA8, CCNB1, CDC23, NUP62, CENPE, KIF18A, PSRC1, KIFC1, KIF2C]
GO:0071548;response to dexamethasone;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;124.89021324540595;6.015873511986907;0.004179963043429046;0.6826520511697386;[PCNA, FECH, ABCB4, PTAFR, FOXO1, AQP1, ICAM1, GHSR, EDN1, TGFB1, ARG1, RPS6KB1, IL1B]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[CSF2, IL5RA, SLA, SLA2, FGF5, EFEMP1, GRAP2, EPHB2, EPHB1, PDGFRB, PDGFRA, MAP2K2, PRKCD, MATK, EREG, BTC, MELK, BTK, EPHA3, EPHA2, BLK, CSF1R, TXK, CSF2RB, CSF2RA, MAP2K6, LYN, LIF, EIF2AK2, BMX, CLK4, PTK2, CLK1, FES, ITK, GHR, JAK3, SYK, RIPK2, IL15, FGR, ZAP70, HCK, LCK, KIT, IL3RA, HBEGF, TTK, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:0060045;positive regulation of cardiac muscle cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;720.414482973016;6.641579411751319;0.024111624414165377;0.7548916918429109;[TGFBR3, MEF2C, CCNB1, CDK1, MAPK14]
GO:0034393;positive regulation of smooth muscle cell apoptotic process;9.0;0.9326813400603323;0.8625812952104552;9.56398573135455;127.00837127343294;7.212124270218933;0.004250855886408647;0.7650689957573628;[IFNG, CDKN2A, ARRB1, SOD2]
GO:0042176;regulation of protein catabolic process;6.0;0.5945822691631375;0.6204114471717133;8.214830917184116;56.791667214012804;3.8826707934156186;0.001900765992470805;0.5216802775280761;[CHEK2, PSMD3, AKT1, TRIB1, NEDD4L, BARD1, PLK2, TNFSF12, PLK1, PTK2, CDKN1B, XPO1, TIMP2, PBK, TIMP3, TIMP1, IL10, CBFA2T3, RNF144A, RNF144B, IL1B, DERL3, CST3, FLNA, IL33, PSMC6, NEDD4, PSMC2, MAD2L1, FMR1, TNF, CLU, LAMP3, HGS, ADAM9, ADAM8, PSMD14, FOXO1, FAM83D, OSBPL7, CAV1, DAB2, CCDC22, LRRK2, TNFAIP3, ALAD, GPX1, IRAK3, TNFRSF1B, IFNG, DTL, CEBPA, LRP1, TAF9, LRP2, AURKA, FYN, SNCA, EGF, PML]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, JUNB, HOXA5, SOX4, MEF2A, MED1, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, TXK, GATA3, GATA1, NHLH2, RAD21, EGR1, EGR2, JUN, BCL11B, FOSL2, FOSL1, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, PLSCR1, TFEC, SATB2, FLNA, CDX2, CDX1, GTF2H1, GRHL2, POU4F1, FOSB, TRIP13, CCNT2, ARID4A, ETS1, HOXA10, PTTG1, LMO2, C5AR1, HMGA1, NFKB1, NFKB2, COPS5, MAFB, FEV, MAFF, ARRB1, ARRB2, MYBL2, MYBL1, MYOCD, KLF13, NCBP2, ETV1, TFDP1, ELF3, IRF7, CREB5, CEBPA, CEBPB, CEBPD, CEBPE, TAF9, LEF1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF6, KLF5, POU2AF1, TAF5, RBMX]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SLA, SLA2, GRAP2, CHEK2, AKT1, NEK2, EPHB1, PDGFRB, PDGFRA, MAP2K2, DAPK1, MATK, VRK1, MELK, BTK, SIK1, BLK, CSF1R, TXK, THY1, LYN, EIF2AK2, BMX, EIF2S1, CLK4, PTK2, CLK1, FES, ATR, ITK, LRRK2, JAK3, MAP4K1, SYK, CAD, IRAK3, FGR, ZAP70, HCK, LCK, KIT, CAMK2D, TTK, AURKB, AURKA, PAK1, FYN, CSK, CAMK4, TEK]
GO:0042177;negative regulation of protein catabolic process;7.0;0.7140352122741334;0.7079369713942671;9.105276108727574;231.8232476428224;5.040875179285974;0.007758915471227624;0.6087099563505541;[ALAD, LAMP3, TIMP2, PBK, TIMP3, TIMP1, IL10, IRAK3, DERL3, TAF9, CST3, FLNA, FYN, SNCA, PML, MAD2L1]
GO:0060968;regulation of gene silencing;6.0;0.6181399273706679;0.6321902762754785;8.242229891372231;28.71512877910424;5.407625775213448;9.610695182985184E-4;0.599666546214876;[FMR1, MAP2K2, SIRT1, DNMT1, UHRF1, CDC45, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, TGFB1, ATAD2, HMGA1, LIN28A, CDK2]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CCNH, RORA, CCNC, NR3C2, CTGF, MED1, NRBP1, RUNX2, MAML3, MAZ, VDR, NR4A2, NR4A1, NR4A3, CDK4, TCF4, CDKN1A, HNF4G, HNF4A, MED23, RARA, YAP1, TAF9, NR1I2, RXRA, POLR2E, E2F2, POLR2I, POLR2J, POLR2K, POLR2L, NR1H2, NR1H4, GTF2H1, TAF5]
GO:0048714;positive regulation of oligodendrocyte differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;471.693664190925;6.943860283624253;0.01578716244373315;0.7703503496879909;[HDAC2, CXCR4, ASPA, TLR2]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[TGFB1, SLC46A2, TNFSF14, RIPK2, CACNA1F, CORO1A, CCNB2, SIT1, BCL2, NCKAP1L, JAK3]
GO:0051445;regulation of meiotic cell cycle;5.0;0.5498737448241444;0.5651778842729924;7.5284634236095505;25.888472835594534;5.8650506222523235;8.664638876944386E-4;0.5901799734356507;[TTK, BRCA2, CDC20, PPP2R1A, FBXO5, PRKACB, DUSP1, LIF, CDC25C, CDC25A, ASPM, MSH2, CDK1, TRIP13, PLCB1]
GO:0009749;response to glucose;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;32.95598622603122;4.917261223318797;0.001103007200523252;0.6023883328937558;[CDKN1B, SLC8A1, CTGF, ICAM1, LGALS1, HNF4A, SOX4, MEN1, RMI1, HNF1B, PAX2, NME1, IL1B, COL6A2, THBS1, EGR1, EIF2B3, TGFB1, LIN28A, RPS6KB1, FKBP1B, NOX4]
GO:0043392;negative regulation of DNA binding;5.0;0.7586651285174919;0.6695735761196662;8.866384200445225;32.533753988449135;5.788089581116195;0.0010888754675157227;0.5862441822128946;[SP100, HDAC2, LEF1, GATA1, E2F1, HMOX1, NEK2, JUN, GZMA, NFKBIA, ID1]
GO:0071850;mitotic cell cycle arrest;7.0;0.8653626801206646;0.7836007053175329;9.420884887713877;120.3495477317274;7.069023426578259;0.00402799105501988;0.7124295520356204;[CDKN1A, CDKN1B, FAP, DUSP1]
GO:0071732;cellular response to nitric oxide;6.0;1.0;0.8231203125901445;9.628524252492122;346.50110413771324;7.004484905440688;0.011597080124741305;0.6813299963962409;[CCNA2, CDK2, FOXO1, DNM2, AQP1]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[CELSR1, CDH3, AP2M1, SOX4, WLS, TLE4, RNF43, SFRP4, HOXB9, SFRP2, CCNE1, DAAM2, PFN1, TCF7, GATA3, APCDD1, PLCG2, FZD1, FZD2, FZD5, FZD8, NR4A2, VANGL1, DAB2, SDC1, SNAI2, CD24, CDK14, LRRK2, TGFB1I1, ARRB2, HHEX, AXIN2, AES, PLCB1, LEF1, FRZB, CTHRC1, EGF, TMEM64, KLF4, LGR4]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ORM1, LRRK2, CLU, PYCARD, IFIH1, CD36, CCR2, HAVCR2, FCER1G, DDX58, RIPK2, CYBB, MIF, HLA-E, TLR1, IL23A, TLR4, TLR2, HDAC2, PTAFR, LY96, TWIST1, NOD2, THBS1, RASGRP1, CCL19, CD14, FZD5, CARD9, AZU1, CD2, PF4]
GO:0010972;negative regulation of G2/M transition of mitotic cell cycle;9.0;0.811012628672052;0.801746939516315;9.394909401310617;357.14964968422294;5.926926025970411;0.011953477361114177;0.699343897778663;[BLM, BRCA1, AURKB, AURKA, RAD21, TOPBP1, NAE1, CLSPN, FANCI, DONSON, CDC6, MSH6, CDK1]
GO:0010971;positive regulation of G2/M transition of mitotic cell cycle;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;355.9636244052406;6.481236761676141;0.011913782162380092;0.7276913745807394;[SMARCD3, VPS4B, CDC7, CDC25C, CDC25A, CCNB1, RAD51C, CDK4, CDK1, DTL]
GO:1900182;positive regulation of protein localization to nucleus;7.0;0.8436909121759173;0.7727648213451592;9.36615998802463;74.62336946219564;5.446340287394138;0.0024975770192273523;0.6294454608352614;[LRRK2, CDH1, AKT1, CCT3, CCT2, MED1, PRKCD, PARP9, IFNG, HCLS1, PTGS2, FYN, CCT8, CCT7, ECT2, CCT5, CCT4, TGFB1, JUP, PLK1, LIF, IGF1, MAPK14, CCT6A, CDK1]
GO:0090267;positive regulation of mitotic cell cycle spindle assembly checkpoint;13.0;0.9326813400603323;0.9288956347978027;9.597752593825367;471.1536740716433;7.8311634786251565;0.015769089460400346;0.8630410292508717;[NDC80, MAD2L1]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[GFI1, TNFAIP3, ARRB1, ARRB2, PYCARD, CYP1B1, HAVCR2, IL10, CHUK, IRAK3, SIRT1, AIM2, NLRC3, PKHD1, G3BP2, NLRP3, CDKN2A, NR1H4, KLF4, NFKBIA, NLRP12, CCDC22, NFKBID]
GO:0061000;negative regulation of dendritic spine development;11.0;0.9326813400603323;0.8987696223598284;9.596775554177542;672.7817568894267;7.292166977892469;0.02251739993881798;0.8053507106995271;[NLGN1, HDAC2, PLK2]
GO:0090266;regulation of mitotic cell cycle spindle assembly checkpoint;12.0;0.8653626801206646;0.8808016526504769;9.548481544818586;280.44081179639056;7.138016298065211;0.009386101590480495;0.8131587980249038;[CDT1, CCNB1, DUSP1, NDC80, MAD2L1]
GO:1900740;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;990.0589542238915;6.599019797332524;0.033136382202663156;0.7527151911823093;[GZMB, TFDP1, TP53BP2, E2F1, BCL2, SFN, YWHAH]
GO:0007344;pronuclear fusion;6.0;1.0;0.8231203125901445;9.628524252492122;29.37726267204044;9.777073627680469;9.832305438132773E-4;0.8231203125901445;[CDK1]
GO:1904668;positive regulation of ubiquitin protein ligase activity;12.0;1.0;0.9481203125901445;9.628524252492122;754.3373369627636;7.212124270218933;0.025246991808615726;0.8169486831672182;[CDC20, UBE2C, UBE2S, PLK1, MASTL, ANAPC10]
GO:1904667;negative regulation of ubiquitin protein ligase activity;12.0;1.0;0.9481203125901445;9.628524252492122;755.449957599424;7.57984905034425;0.025284230220031186;0.835754145523778;[FBXO5, MAD2L1]
GO:1902916;positive regulation of protein polyubiquitination;11.0;0.8436909121759173;0.8542744084176208;9.519324960527129;611.6426321926975;7.474488534686424;0.020471128456858376;0.8146746435927894;[PTPN22, NOD2, SKP2, BIRC2]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[SPI1, EHMT2, SLA2, AKT1, MEF2A, MEF2C, ATF3, GATA3, IQGAP3, GATA1, HESX1, JUN, EIF2AK2, NR2F2, DHFR, PKIA, PKIG, EZH2, SIRT1, SRP9, MMP12, BTAF1, FLNA, STAT1, CENPF, LGR4, GMNN, CTGF, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CIITA, LRRK2, FHL2, PIK3CD, FASLG, FOXM1, HHEX, ITGB8, PEG3, BIRC5, BIRC2, BIRC3, UHRF1, E2F1, FYN, E2F7, E2F8, PRRX1, EIF3E, IKZF1, UXT, HNF1B, MIF, EREG, SFRP2, IFI27, KCNQ1, NAIP, GSPT1, BRIP1, PCBP3, A2M, CCR1, EGR1, MSR1, ID1, CD28, SUV39H2, SUV39H1, CTSZ, PTPRK, BRCA1, CD3E, BMI1, CD38, CD36, CD34, BANK1, IL1B, DEPDC1, SATB2, RELB, RXRA, NEDD4, LOXL2, EOMES, CCNE1, CALCA, TCF7, CCNB1, VDR, CAV1, HMGA1, BMP2, UBA3, MXD1, HMGB2, MYOCD, NCBP2, GREM1, ELF3, IRF7, IRF8, FBP1, AURKB, TBX21, SERPINE1, PHB2, MYB, HOXA2, HOXA7, JUNB, MED1, DAPK1, HOXB4, HOXB3, SERPING1, NEDD4L, PRDM16, ELANE, BARD1, FZD1, NDFIP2, PLK1, FZD8, UPF3B, SNAI2, CDKN1A, BTG2, CDKN1B, HAVCR2, HELLS, PAWR, PAX5, PAX2, AES, ZEB1, TAL1, RARA, GAS1, HCLS1, PLCB1, ENG, NR1I2, ASCL2, CDKN2A, NR1H2, NR1H4, POU4F1, FOSB, CSF2, FMR1, TNF, DACH1, MEN1, TLE4, MAP2K2, IGFBP5, DNMT1, AEBP1, NACC2, WFS1, LSM5, LSM3, DAB2, BCL6, CNOT3, BCL3, CDK2, PTPN22, EMILIN1, CR1, RFC1, PTBP2, XCL1, CEBPA, CEBPB, HDAC2, NLRC4, RBBP8, ZNF503, KLF4, PML, KLF8, KLF5, DNAJA3, GFI1, ZNF608, EDNRB, PPP2R1A, MAGOH, DPF3, SOX7, SOX4, IL1R2, RUNX2, TWIST1, BCL11A, IFNA2, XPO1, HBZ, EDN1, NOG, PARP9, CBFA2T3, NME1, MDFIC, SP100, TYMS, AIF1, PURA, APBB1, CDX2, MLH1, LILRB4, ARID4A, CHCHD3, BASP1, TIMELESS, TGFB2, TGFB1, CBX4, EIF2S1, NR4A2, LIN28A, NR4A3, CREBZF, KLF12, H2AFX, RBL2, RBL1, IFNG, PFDN5, LEF1, THBS1, SNCA, MEIS2, RBMX]
GO:0071285;cellular response to lithium ion;6.0;1.0;0.8231203125901445;9.628524252492122;77.8106912628645;7.212124270218933;0.002604253811492351;0.6919486831672181;[CEBPA, CDKN1B, CDH1]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[CDKN1B, TMEM100, HHEX, HNF1B, FCER2, MAML3, CEBPA, PSEN2, KCNA5, DTX3, DLL1, PLN, GMDS, PERP, S1PR3, ZNF423, TGFB1, JAG1, NR1H4, KRT19, BMP2, IL2RA, SNAI2]
GO:0071283;cellular response to iron(III) ion;7.0;1.0;0.8509193652572005;9.628524252492122;96.28817659807011;9.083926447120524;0.003222678617004505;0.8154717862087246;[CCNB1]
GO:0070194;synaptonemal complex disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;39.82835148474282;9.083926447120524;0.0013330190810051427;0.7876727335416686;[PLK1]
GO:0071168;protein localization to chromatin;7.0;0.7369933605727446;0.7194160455435727;8.935377071932177;34.71951895434896;6.832634648514029;0.001162031053863633;0.7003406189322132;[RUVBL2, RAD21, PLK1, ESCO2, EZH2]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, GATA1, C3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, DLGAP5, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, PTAFR, STAT4, SPP1, STAT1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CXCL10, MYD88, CIITA, FHL2, PIK3CD, ARRB1, ARRB2, FOXM1, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, UHRF1, CCL5, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, CCNC, IKZF1, TNFSF11, EPHB2, HNF1B, SFRP4, SFRP2, EGR1, EGR2, EGR3, IGF1, ID1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3E, CD3D, HNF4A, CTSH, CD38, CD36, CD34, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RELB, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, ACTG2, EOMES, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, NAT8, TCF4, IL7R, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL2, MYBL1, YWHAH, MYOCD, DDX58, NCBP2, ETV1, ACTA2, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, RNF6, TBX21, RBM38, EGF, MAPK14, CD4, TNIP3, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, PRKDC, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD2, FZD5, FZD8, UPF3B, FOSL2, FOSL1, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, ZEB1, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, FAM129A, EPCAM, GSN, NR1H2, NR1H4, GTF2H1, POU4F1, PLP1, FOSB, PF4, CSF3, CSF2, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, LAMP3, MEN1, MAP2K2, F2R, ADAM2, ADAM8, DNMT1, DAB2, COPS5, MAFB, CDK4, MAFF, BCL3, CDK2, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK2, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EPB41L4B, EDN1, NOG, RHOG, PARP9, MDFIC, TFEC, TLR6, TLR4, TLR2, SP100, APBB1, CDX2, CDX1, LILRB1, GRHL2, CAMK4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, SLC40A1, CKS1B, KLF13, CKAP2, AXIN2, DCN, DNM2, RBL1, IFNG, LEF1, DLL1, THBS1, S1PR1, LUM, MEIS2, MEIS1, RPS6KB1, RBMX]
GO:0070198;protein localization to chromosome, telomeric region;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;34.71951895434896;7.138016298065211;0.001162031053863633;0.7159578506919597;[BRCA2, ATR]
GO:0055015;ventricular cardiac muscle cell development;7.0;1.0;0.8509193652572005;9.628524252492122;69.56390858866273;7.379178354882098;0.002328241417009372;0.728290889492758;[CCNB1, CDK1, FHL2, MYH10]
GO:0032876;negative regulation of DNA endoreduplication;10.0;1.0;0.9152410118609203;9.628524252492122;1221.9246883190933;7.9853141584524145;0.04089671965721659;0.8236103492792612;[MSH6, STAG2, SMC1A, SMC3]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, CHEK2, AKT1, STK32B, MAP2K2, PRKCH, PRKCB, PRKCE, PRKCD, VRK1, PRKCQ, PRKDC, PRKCZ, CCNB1, CLSPN, PLK2, PLK1, CDC7, CLK1, CDK2, CDK1, BCL2, ATR, LRRK2, MAP4K1, CHUK, SYK, MASTL, SGK1, CAMK2D, TTK, AURKB, AURKA, MAPK14, MAPK13, RPS6KB1, CAMK4, PKN1, CAMK1]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[LRRK2, CHEK2, CHEK1, AKT1, PRKCB, PRKCD, CAD, VRK1, CAMK2D, TTK, CLK1, CDK1, BCL2, PKN1, CAMK1]
GO:0010862;positive regulation of pathway-restricted SMAD protein phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1012.5567145242198;5.905872616772578;0.033889361993245395;0.7172676121338334;[TGFB2, TGFB1, TTK, INHBA, BMP2, DAB2, ENG]
GO:0033160;positive regulation of protein import into nucleus, translocation;10.0;1.0;0.9152410118609203;9.628524252492122;970.0189350156829;7.292166977892469;0.03246566079461078;0.7881627702307852;[MED1, IFNG, LRRK2, CDK1, IGF1]
GO:0032077;positive regulation of deoxyribonuclease activity;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;813.6405734422207;8.16763571524637;0.027231817764135358;0.7926932703116032;[PCNA, PRKCD, AKT1]
GO:0006344;maintenance of chromatin silencing;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;21.24116723228514;8.390779266560578;7.10922751455178E-4;0.7193458537639684;[HDAC2, SIRT1]
GO:0045347;negative regulation of MHC class II biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.30203964950672;8.16763571524637;0.0049300667038400395;0.7686126355688037;[IL10, HDAC2, SPI1, PF4]
GO:0044257;cellular protein catabolic process;6.0;0.7763722522362496;0.7113064387082693;9.277126365654233;323.3351550789029;6.193554689224359;0.01082173665774351;0.6398589874268261;[DENND3, CHEK2, LAMP2, AP2M1]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[, SLA2, MYLK, AKT1, PRKACB, MEF2A, MED1, MEF2C, PRKCH, DAPK1, PRKCB, PRKCE, PRKCD, PRKAR1B, PRKCQ, PRKDC, PDGFA, THY1, IQGAP3, PRKCZ, LYN, PLK4, PLK2, PLK1, EIF2AK2, CDC7, CDK14, ITK, PBK, JAK3, RIPK2, DUSP6, CIT, RARA, HBEGF, NRAS, IL12RB2, GTF2H1, PKN1, CCNT2, CSF2, IL5RA, SLA, TNF, FGF5, EFEMP1, GRAP2, MAP3K8, NEK2, STK32B, KCNH1, MEN1, KCNH2, MAP2K2, IGFBP3, VRK1, NRBP1, MELK, BLK, CSF1R, RASAL2, PKMYT1, MAP2K6, NEK7, BMX, NFKB1, CDK6, CDK4, CDK2, CDK1, BCL2, LAT, LRRK2, PIK3CD, TLK1, CHUK, SPTB, LCK, IL3RA, BIRC5, PIK3C3, TTK, NOD2, IL2RG, CCL8, CCL5, CCL2, FYN, CSK, TIE1, PML, IL2RA, IL2RB, PTPN6, CCNH, CCNC, CHEK2, CHEK1, RPS6KA1, TNFSF11, EPHB2, EPHB1, PAQR3, EREG, BTC, BTK, SIK1, ALPK2, TRIB1, EPHA3, EPHA2, TXK, LIF, IGF1, PTK2, ATR, CTSH, CTSG, CCR5, SPTAN1, MAP4K1, SYK, IL15, STRADB, IL18, GFRA3, HCK, IL1B, KIT, FAM20C, TLR7, SGK1, TLR4, TLR2, GUCY2C, PAK1, PRKY, KITLG, CAMK4, CAMK1, BUB1B, PDGFRB, PDGFRA, MATK, CCNE1, CSF2RB, CSF2RA, RASGRP1, RASGRP4, SPTA1, CCNB1, CLSPN, TGFB2, TGFB1, EIF2S1, CLK4, CLK1, BMP2, FES, GHR, CAD, IRAK3, MASTL, TGFBR3, FGR, CCNA2, ZAP70, SHANK3, CAMK2D, AURKB, AURKA, NCAM1, BUB1, EGF, MAPK14, MAPK13, WEE1, RPS6KB1, TEK]
GO:0060623;regulation of chromosome condensation;7.0;0.8259837884571596;0.7639112594857803;9.377209824211215;21.750886949199476;8.390779266560578;7.279826116623381E-4;0.7800242071602487;[CCNB1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, PKIA, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, ZEB1, TAL1, RARA, HCLS1, ASCL2, STAT1, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CDK2, CIITA, FHL2, FASLG, FOXM1, HHEX, RFC1, PEG3, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, E2F8, PRRX1, KLF4, KLF8, KLF5, DNAJA3, GFI1, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H2, SUV39H1, BMI1, XPO1, CD36, HBZ, EDN1, NOG, PARP9, IL1B, SP100, SATB2, RELB, RXRA, APBB1, CDX2, LILRB4, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TIMELESS, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, RBL1, IFNG, IRF7, IRF8, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0010718;positive regulation of epithelial to mesenchymal transition;6.0;0.811012628672052;0.7286266269261705;9.377209824211215;170.70262580884207;5.9928839937622085;0.005713263263432726;0.6295966787287501;[HDAC2, TGFB1I1, LEF1, TWIST1, LOXL2, EPB41L5, PDPN, TGFB2, TGFB1, AXIN2, COL1A1, BMP2, DAB2, IL1B, EZH2, ENG]
GO:0046680;response to DDT;5.0;1.0;0.7902410118609202;9.628524252492122;46.407574972267774;9.777073627680469;0.0015532197702158826;0.7902410118609202;[CCNB1]
GO:0032869;cellular response to insulin stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;5.334422371190153;0.015486127626965131;0.6478026081386739;[CYFIP1, AKT1, GHSR, CEACAM1, RAB31, PRKDC, FOXO1, PAK1, STAT1, SORBS1, RPS6KB1, CDK4]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[CSF3, SPI1, SPARC, TNC, ICAM1, EEF1B2, ALAD, PRKCE, CYBB, ADCYAP1, CLDN3, IL1B, CLDN7, RARA, S100A8, BIRC2, PSMD14, FECH, GATA3, TYMS, CCL7, CNR1, FYN, CD14, GSN, VCAM1, GGH, RPS6KB1, CDK1, CD27]
GO:0097421;liver regeneration;6.0;1.0;0.8231203125901445;9.628524252492122;47.21654787453615;6.250713103064308;0.0015802953652264606;0.6427820713687392;[IL10, CEBPB, PCNA, TGFB1, IHH, TYMS, SULF2, AURKA, NFKBIA, HMOX1, EZH2]
GO:0031658;negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle;13.0;1.0;0.9625549647676366;9.628524252492122;3330.314475181895;7.8311634786251565;0.11146262839589782;0.8630410292508717;[CDKN2C, CDK6, CDKN2A, CDK4]
GO:0032508;DNA duplex unwinding;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;23.726073882073138;5.734022359845919;7.940903407527885E-4;0.64415753539903;[BLM, MCM7, RAD54B, PURA, BRIP1, CDC45, RUVBL2, RUVBL1, GINS1, GINS2, ANXA1, GINS4, HMGA1, RPA1, RAD50, RAD51, MCM4, MCM6, DNA2, MCM2]
GO:0033158;regulation of protein import into nucleus, translocation;9.0;0.8933024483968273;0.8428918493787028;9.517298617381897;190.5797269763205;6.943860283624253;0.006378531951278581;0.7513499630073597;[MED1, CDKN1A, IFNG, LRRK2, CDK1, IGF1, SIRT1]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[PROS1, SERPINE1, SPINT2, AQP1, PTTG1, LAMP3, RPS6KA1, AKT1, APLP2, POR, SFRP2, SPINT1, SLPI, SERPING1, NAIP, C3, SFN, A2M, TNFSF14, TNFRSF10C, CRIM1, TNFRSF10B, DHCR24, VIL1, CD27, TNFAIP8, SERPINA1, ARRB1, ARRB2, TIMP2, TIMP3, TIMP1, CR1, SERPINB2, GPX1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, COL6A3, BIRC5, BIRC2, LTF, BIRC3, SERPINB10, CSTA, LEF1, IFI6, NLRC4, PTGS2, CST7, THBS1, CST3, SPOCK2, SPOCK3, SNCA, KLF4, FABP1]
GO:2000210;positive regulation of anoikis;8.0;1.0;0.875;9.628524252492122;103.81651994310933;7.8311634786251565;0.0034746454936938316;0.7754860644832351;[CHEK2, SIK1, AES]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[HDAC2, PCNA, TNFAIP3, ETS1, FOXO1, AQP1, CST3, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[PTPRR, PTPN22, PTPRK, DUSP10, DUSP2, DUSP3, DUSP1, CDC25C, DUSP6, CDC25A, TPTE, PTPRE, PTPRC, PTPN6, PTPN7, PTPN4, CDKN3]
GO:1903351;cellular response to dopamine;8.0;1.0;0.875;9.628524252492122;545.6259493406901;7.138016298065211;0.018261609492958953;0.7400384854347593;[HDAC2, LRRK2, ID1, DNM2]
GO:0090129;positive regulation of synapse maturation;7.0;0.9326813400603323;0.8172600352873667;9.571365838652174;185.50285720788708;7.57984905034425;0.006208613689015268;0.738553198190834;[CDC20]
GO:0042769;DNA damage response, detection of DNA damage;5.0;0.7866048967936545;0.6835434602577475;9.143016436710422;39.83823472227698;6.139487467954083;0.0013333498640710748;0.6042146864874571;[PCNA, POLD3, POLD1, USP1, SOX4, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA2, RPA3, DTL]
GO:1900087;positive regulation of G1/S transition of mitotic cell cycle;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;354.40743100732976;6.409777797693995;0.011861697769835146;0.7240369598395108;[ANXA1, KCNA5, CDC6, AIF1, CDC45, PLCB1]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MNX1, MEF2A, MEF2C, PADI4, ATF3, CDCA7, GATA3, GATA1, HESX1, MCTS1, JUN, HACE1, EIF2AK2, NR2F2, EZH2, HOXC10, CHAF1B, ACTL6A, FOS, SIRT1, PLSCR1, STAT4, FLNA, ZNF467, CASP8AP2, STAT1, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CIITA, FHL2, FASLG, ARRB1, ARRB2, FOXM1, HHEX, BIRC5, BIRC2, UHRF1, ZBTB41, E2F1, E2F5, E2F7, E2F8, PRRX1, POU2AF1, CCNH, IKZF1, UXT, HNF1B, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H2, SUV39H1, BRCA1, BMI1, DEPDC1, SATB2, RELB, IL33, FOXA3, FOXA2, ETS1, LOXL2, EOMES, TCF7, LPXN, HMGA1, MXD1, PHTF2, HMGB2, AFF3, LYL1, NUP62, MYBL2, MYBL1, MYOCD, NCBP2, ETV1, ELF3, IRF7, IRF8, ZMYND11, CREB5, TAF9, TBX21, MAPK14, MAPK13, TAF5, NAA15, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA6, HOXA5, HOXA4, MED1, PRKCB, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, ASF1B, RAD21, PRDM16, NKX2-3, NFE2, FOSL2, FOSL1, SNAI2, BTG2, TGFB1I1, ZNF367, TCF19, BRD2, HELLS, PAWR, PAX5, PAX2, AES, ZEB1, TAL1, ASCL2, GTF2H1, POU4F1, FOSB, MEN1, TLE4, DNMT1, AEBP1, NACC2, MAP2K6, HOPX, COPS5, MAFB, BCL6, CNOT3, MAFF, BCL3, LBH, RFC1, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, MNDA, GFI1, ZNF608, CHEK2, DPF3, SOX7, SOX4, EBF1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, TFEC, SP100, PURA, APBB1, CDX2, CDX1, GRHL2, TRIP13, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, PTTG1, LMO2, COL4A2, TIMELESS, C5AR1, NLRP3, CBX4, NR4A2, FEV, CREBZF, KDM5D, KLF12, KLF13, RBL2, RBL1, LTF, LEF1, HLX, MEIS2, MEIS1, RBMX]
GO:1905775;negative regulation of DNA helicase activity;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;205.113589991404;9.777073627680469;0.006864967266765914;0.896240625180289;[MCM2]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[TGFB1I1, RORA, GATA3, TNF, FOXO1, E2F1, TGFB1, JAG1, SORT1, SIRT1, IL6]
GO:0007569;cell aging;3.0;0.7980440201809971;0.597142322680643;8.935377071932177;24.751975343904395;5.618190544320798;8.284263394289076E-4;0.485434838299289;[CDKN1A, SERPINE1, BRCA2, ICAM1, CHEK2, NUP62, CHEK1, MME, CDKN2A, PRKCD, H2AFX, HMGA1, MIF, MAPK14, SIRT1, PML, DNAJA3, CDK1, BCL2, NOX4, ENG, ATR]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[PID1, SPI1, EHMT2, SLA2, SPIB, AKT1, MNX1, MEF2A, WDHD1, MEF2C, ZFYVE16, ATF3, GATA3, GATA1, HESX1, JUN, JAG1, JUP, NR2F2, PKIA, PKIG, EZH2, HOXC10, DLGAP5, RIPK2, ACTL6A, FOS, SIRT1, MMP12, MED23, PLSCR1, CKS2, PTAFR, FSTL1, STAT4, ZNF467, STAT1, USP9Y, ATAD2, NOC3L, PSMC6, PSMC2, PKN1, CCNT2, RORA, RUVBL2, RUVBL1, ADCYAP1, MAZ, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, FASLG, ARRB1, FOXM1, HHEX, PPP1R12A, PEG3, UHRF1, LRP2, ZBTB41, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, POU2AF1, SMARCAL1, CCNH, CCNC, IKZF1, UXT, TNFSF11, HNF1B, SFRP4, SFRP2, IFI27, TGFA, BRIP1, PCBP3, ZNF700, EGR1, EGR2, EGR3, IGF1, ID1, CD28, SUV39H2, ECM1, CD40, SUV39H1, HNF4G, BRCA1, PCSK6, BMI1, CD3D, HNF4A, CD36, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RELB, RXRA, IL33, OSM, NEDD4, FOXA3, IL17A, FOXA2, IHH, ETS1, NR3C2, LOXL2, EOMES, CCNE1, TCF7, HTRA1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, MXD1, FBN1, PLEK, HMGB2, ARHGEF10L, LYL1, MYBL2, MYBL1, MYOCD, DDX58, ETV1, GREM1, ELF3, IRF7, IRF8, ZMYND11, FBP1, CREB5, TAF9, AURKB, TBX21, MAPK14, SOD2, TNIP3, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA6, HOXA5, HOXA4, MED1, PRKCB, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB6, HOXB5, PRKDC, NEDD4L, RAD21, PRDM16, HMOX1, ELANE, NKX2-3, FZD1, NFE2, FZD5, PLK1, FZD8, FOSL2, FOSL1, SNAI2, CDKN1A, BTG2, ZNF367, HAVCR2, TCF19, BRD2, PAWR, PAX5, PAX2, AES, ZEB1, TAL1, RARA, HCLS1, ENG, NR1I2, ASCL2, EPCAM, NR1H2, NR1H4, GTF2H1, ELP4, SULF1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, NACC2, WFS1, HOPX, COPS5, MAFB, BCL6, MAFF, BCL3, CDK2, CYR61, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, RBBP8, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, DNAJA3, PPIL4, GFI1, ZNF608, EDNRB, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, IL23A, PFN1, NBL1, BEX1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, LIF, TOP2A, AHCTF1, PRL, XPO1, HBZ, EDN1, NOG, PARP9, TFEC, TLR4, TLR2, SP100, PURA, APBB1, CDX2, CDX1, LILRB1, GRHL2, LILRB4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, PTTG1, LMO2, TIMELESS, ADRB2, NLRP3, TGFB2, TGFB1, CBX4, NR4A2, NFKBIA, NR4A1, NR4A3, FEV, JMY, NFKBID, CREBZF, KDM5D, SLC40A1, TMEM100, KLF12, KLF13, CKAP2, DCN, TGFBR3, RBL2, RBL1, IFNG, CAMK2D, LEF1, DLL1, HSPD1, HLX, S1PR1, SNCA, LUM, MEIS2, MEIS1, RBMX]
GO:0001578;microtubule bundle formation;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;33.1981629444775;5.8067817141283475;0.0011111126373447525;0.6200793994936333;[PLK1, NAV1, PSRC1, FES, PRC1, MAP1B, KIF20A]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, PRKDC, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CDKN1B, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, HCLS1, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, CSF2, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, DNMT1, CORO1A, FOXO1, SOCS2, TXNDC5, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, GPX1, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, IGF1, PTK2, VNN1, ID1, CD28, CD27, NRP1, KIF14, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, NOG, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, CASP2, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, AURKA, SNCA, SOD2, RPS6KB1, TEK, NAA15]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, PRKDC, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, FOSL1, NOX4, NOX1, SRPX, ADM, CTLA4, TIMP3, ANXA1, DUSP1, RIPK2, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, CDKN2A, G0S2, POU4F1, TNF, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A9, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, CDK4, BCL2, BCL2L1, PLEKHF1, PIK3CD, FASLG, ARRB1, ARRB2, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, GZMA, GZMB, PML, P2RX1, MNDA, IFIT2, PPP2R1A, CHEK2, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, GADD45B, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, IL10, VAV1, IL1B, CXCR2, CTNNA1, APBB1, SORT1, AKR1C3, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, TGM2, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, NFKBID, UBE2M, TNFAIP8, CASP2, MYBL2, YWHAH, ARHGEF12, PLAUR, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
GO:0033148;positive regulation of intracellular estrogen receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;233.77170011230152;7.379178354882098;0.007824128421887714;0.7523715242355574;[, YAP1, MED1, PAK1, SKP2]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[NCF2, ITGB3, NCF4, ICAM3, ITGAL, CD36, TGM2, ANXA1, CD93, ANXA3, SLC11A1, DNM2, PECAM1, RARA, IRF8, PRTN3, CD302, LRP1, CEBPE, PLD4, CORO1A, CD14, ELANE, SLAMF1, TXNDC5, CDC7, MARCO]
GO:0032298;positive regulation of DNA-dependent DNA replication initiation;10.0;0.8933024483968273;0.861892236059334;9.566003895510788;1058.995272857269;9.777073627680469;0.03544361874866342;0.9152410118609203;[CDK2]
GO:0032732;positive regulation of interleukin-1 production;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.64212018022187;6.063501560976162;0.0021969826883592772;0.6332080644001243;[ORM1, HDAC2, NOD2, PYCARD, NLRP3, CCL19, HAVCR2, EGR1, FZD5, CCL20, RIPK2, AZU1, NLRP12, AIM2, IGHD, TLR8, TLR4]
